<SEC-DOCUMENT>0001193125-24-018300.txt : 20240129
<SEC-HEADER>0001193125-24-018300.hdr.sgml : 20240129
<ACCEPTANCE-DATETIME>20240129172117
ACCESSION NUMBER:		0001193125-24-018300
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240129
DATE AS OF CHANGE:		20240129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brookfield Reinsurance Ltd.
		CENTRAL INDEX KEY:			0001837429
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE CARRIERS, NEC [6399]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276533
		FILM NUMBER:		24574753

	BUSINESS ADDRESS:	
		STREET 1:		IDEATION HOUSE, 1ST FLOOR
		STREET 2:		94 PITTS BAY ROAD
		CITY:			PEMBROKE
		STATE:			D0
		ZIP:			HM08
		BUSINESS PHONE:		441-405-7811

	MAIL ADDRESS:	
		STREET 1:		IDEATION HOUSE, 1ST FLOOR
		STREET 2:		94 PITTS BAY ROAD
		CITY:			PEMBROKE
		STATE:			D0
		ZIP:			HM08

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Brookfield Asset Management Reinsurance Partners Ltd.
		DATE OF NAME CHANGE:	20201221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BROOKFIELD Corp /ON/
		CENTRAL INDEX KEY:			0001001085
		STANDARD INDUSTRIAL CLASSIFICATION:	OPERATORS OF NONRESIDENTIAL BUILDINGS [6512]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276533-01
		FILM NUMBER:		24574755

	BUSINESS ADDRESS:	
		STREET 1:		BROOKFIELD PLACE, 181 BAY ST, STE 100
		STREET 2:		PO BOX 762
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5J2T3
		BUSINESS PHONE:		416-363-9491

	MAIL ADDRESS:	
		STREET 1:		BROOKFIELD PLACE, 181 BAY ST, STE 100
		STREET 2:		PO BOX 762
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5J2T3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BROOKFIELD ASSET MANAGEMENT INC.
		DATE OF NAME CHANGE:	20051116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRASCAN CORP/
		DATE OF NAME CHANGE:	20010321

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDPERBRASCAN CORP
		DATE OF NAME CHANGE:	19970904
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d723741d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML><HEAD>
<TITLE>424B3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed pursuant to Rule 424(b)(3)<BR>Registration Nos. 333-276533 and 333-276533-01 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723741g13w60.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>BROOKFIELD REINSURANCE LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>BROOKFIELD CORPORATION </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>US$1,500,000,000 </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Class&nbsp;A Exchangeable Limited Voting Shares of Brookfield Reinsurance Ltd. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Class&nbsp;A-1</FONT> Exchangeable <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Shares of Brookfield
Reinsurance Ltd. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Offered by Brookfield Reinsurance Ltd. </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Class&nbsp;A Limited
Voting Shares of Brookfield Corporation (issuable or deliverable upon exchange, redemption or acquisition of Class&nbsp;A Exchangeable Limited Voting Shares or <FONT STYLE="white-space:nowrap">Class&nbsp;A-1</FONT> Exchangeable <FONT
STYLE="white-space:nowrap">Non-Voting</FONT> Shares of Brookfield Reinsurance Ltd.) </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Up to 765,488 Class&nbsp;A Exchangeable Limited Voting Shares of Brookfield Reinsurance Ltd. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Up to 243,104 <FONT STYLE="white-space:nowrap">Class&nbsp;A-1</FONT> Exchangeable <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Shares of
Brookfield Reinsurance Ltd. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Offered by Selling Securityholders </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">Brookfield Reinsurance Ltd. (&#147;<B>Brookfield Reinsurance</B>,&#148; our &#147;<B>company</B>&#148;, &#147;<B>we</B>&#148;,
&#147;<B>us</B>&#148; and &#147;<B>our</B>&#148;) may, from time to time, issue up to US$1,500,000,000 of its class A exchangeable limited voting shares (the &#147;<B>class A exchangeable shares</B>&#148;, and each, a &#147;<B>class A exchangeable
share</B>&#148;) and class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable <FONT STYLE="white-space:nowrap">non-voting</FONT> shares (the &#147;<B>class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares</B>&#148;, and together
with the class A exchangeable shares, the &#147;<B>exchangeable shares</B>&#148;, and each, an &#147;<B>exchangeable share</B>&#148;). Each exchangeable share is structured with the intention of providing an economic return equivalent to one class A
limited voting share (a &#147;<B>Brookfield Class</B><B></B><B>&nbsp;A Share</B>&#148;) of Brookfield Corporation (&#147;<B>Brookfield Corporation</B>&#148;), subject to adjustment to reflect certain capital events. Each exchangeable share is
exchangeable at the option of the holder for one Brookfield Class&nbsp;A Share (subject to adjustment to reflect certain capital events) or its cash equivalent (the form of payment to be determined at the election of Brookfield Corporation). Each
exchangeable share receives distributions at the same time and in the same amount per share as the cash dividends paid on each Brookfield Class&nbsp;A Share. We therefore expect that the market price of our exchangeable shares should be impacted by
the market price of the Brookfield Class&nbsp;A Shares and the business performance of Brookfield Corporation. </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">In addition, this prospectus
relates to the offer and resale from time to time by selling securityholders of up to 765,488 class A exchangeable shares and up to 243,104<B> </B>class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares. See &#147;Selling
Securityholders.&#148; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">This prospectus also relates to (i)&nbsp;the class A exchangeable shares that may be issuable upon conversion of the
class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares (subject to certain limitations as further described in this prospectus) and (ii)&nbsp;the issuance by Brookfield Corporation or delivery by Brookfield Reinsurance of Brookfield
Class&nbsp;A Shares deliverable to holders of exchangeable shares issued by our company or resold by the selling securityholders to satisfy any exchange, redemption or acquisition of exchangeable shares (including in connection with any liquidation,
dissolution or winding up of our company). </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">You should carefully read this prospectus and any accompanying prospectus supplement, together
with the documents our company and Brookfield Corporation incorporate by reference, before you invest in the securities described herein. </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman">Our class A exchangeable shares are traded on the New York Stock Exchange (the &#147;<B>NYSE</B>&#148;) and the Toronto Stock Exchange (the
&#147;<B>TSX</B>&#148;) under the symbol &#147;BNRE&#148;. Our class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares are traded on the NYSE and the TSX under the symbol &#147;BNRE.A&#148;. The Brookfield Class&nbsp;A Shares are
traded on the NYSE and the TSX under the symbol &#147;BN&#148;. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:5%; font-size:11pt; font-family:Times New Roman"><B>An investment
in the exchangeable shares and the Brookfield Class&nbsp;A Shares involves a high degree of risk. See &#147;<A HREF="#toc723741_6">Risk Factors</A>&#148; beginning on page 4. </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman"><B>This
prospectus may not be used to consummate sales of exchangeable shares unless it is accompanied by a prospectus supplement. Any net proceeds the company or any selling securityholder, as the case may be, expects to receive from the sale of the
exchangeable shares will be set forth in a prospectus supplement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is January&nbsp;29, 2024. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_2">CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_3">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">vi</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_4">DOCUMENTS INCORPORATED BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">vi</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_5">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_8">DESCRIPTION OF OUR EXCHANGEABLE SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_9">DESCRIPTION OF BROOKFIELD CLASS A SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_10">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_11">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_12">SERVICE OF PROCESS AND ENFORCEABILITY OF CIVIL LIABILITIES</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_13">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_14">TRANSFER AGENT AND REGISTRAR</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_15">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723741_16">EXPENSES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on Form <FONT STYLE="white-space:nowrap">F-3</FONT> that our company and Brookfield
Corporation have filed with the Securities and Exchange Commission (the &#147;<B>SEC</B>&#148;) under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), using a shelf registration process. Under this shelf registration
process, we may sell, or a selling securityholder may sell, the exchangeable shares (and the underlying Brookfield Class&nbsp;A Shares) pursuant to this prospectus or through underwriters or dealers directly pursuant to applicable statutory
exemptions, or through agents designated by us or the selling securityholders from time to time. Each prospectus supplement will identify each person who may be deemed to be an underwriter and will set forth the terms of the offering, including, to
the extent applicable, the purchase price or prices of the offered exchangeable shares, the initial offering price, the proceeds to us or the selling securityholders from the sale of the offered exchangeable shares, any underwriting discounts and
other items constituting underwriters&#146; compensation and any discounts or concessions allowed or <FONT STYLE="white-space:nowrap">re-allowed</FONT> or paid to dealers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exchangeable shares may be offered and sold in amounts, at prices and on terms to be determined based on market conditions as set forth in
one or more accompanying prospectus supplements (each a &#147;<B>prospectus supplement</B>&#148;). This prospectus provides you with a general description of the exchangeable shares and the Brookfield Class&nbsp;A Shares. Each time our company or
the selling securityholders sell exchangeable shares hereunder, our company and Brookfield Corporation will provide a prospectus supplement that will contain specific information about the terms of that offering. The prospectus supplement may also
add, update or change information contained in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As allowed by the SEC rules, this prospectus does not contain all the
information included in the registration statement. For further information, you are referred to the registration statement, including its exhibits, as well as any prospectus supplement and any documents incorporated by reference herein or therein.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus together with any applicable prospectus supplement thereto, and in any &#147;free writing
prospectus&#148; that we may provide to you, and any documents incorporated by reference herein or therein and any additional information you may need to make your investment decision. You should also read and carefully consider the information in
the documents we have referred you to in &#147;Where You Can Find More Information&#148; and &#147;Documents Incorporation by Reference&#148; below. Information incorporated by reference after the date of this prospectus is considered a part of this
prospectus and may add, update or change information contained in this prospectus. The information in this prospectus or any document incorporated herein by reference is accurate only as of the date contained on the cover of such documents. Neither
the delivery of this prospectus nor any delivery of the exchangeable shares or Brookfield Class&nbsp;A Shares made under this prospectus will, under any circumstances, imply that the information in this prospectus is correct as of any date after
this prospectus. Our business, financial condition and results of operations may have changed since that date. Any information in such subsequent filings that is inconsistent with this prospectus will supersede the information in this prospectus.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information incorporated by reference or provided in this prospectus and any accompanying prospectus
supplement, and in any &#147;free writing prospectus&#148; that we may provide to you. We have not authorized anyone else to provide you with other information. Neither we nor the selling securityholder are making an offer to sell these securities
in any jurisdiction where the offer or sale is not permitted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context requires otherwise, when used in this prospectus, the
terms &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; &#147;Brookfield Reinsurance&#148; and &#147;our company&#148; mean Brookfield Reinsurance Ltd. together with all of its subsidiaries and the term &#147;Brookfield&#148; means Brookfield
Corporation (formerly Brookfield Asset Management Inc.), its subsidiaries and controlled companies, and, unless the context otherwise requires, Brookfield Asset Management Ltd., and any investment fund sponsored, managed or controlled by Brookfield
Corporation or its subsidiaries, and does not, for greater certainty, include us or Oaktree Capital Group, LLC or Atlas OCM Holdings, LLC and its subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Your ability to enforce civil liabilities under the United States federal securities laws
may be affected adversely because our company is organized under the laws of Bermuda and Brookfield Corporation is organized under the laws of Ontario, Canada, certain of the directors of our company and Brookfield Corporation as well as certain of
the experts named in this prospectus are residents of Canada or another non-U.S. jurisdiction and a substantial portion of our company&#146;s and Brookfield Corporation&#146;s assets and the assets of those directors and experts may be located
outside the United States. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this prospectus and any prospectus supplement, unless otherwise indicated, all dollar amounts and
references to &#147;$&#148; or &#147;US$&#148; are to U.S. dollars. The financial statements of our company incorporated by reference herein have been prepared in accordance with the accounting principles generally accepted in the United States of
America (&#147;<B>U.S. GAAP</B>&#148;). The financial statements of Brookfield Corporation incorporated by reference herein have been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting
Standards Board. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_2"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus and the documents incorporated by reference herein contain forward-looking information and other &#147;forward looking
statements&#148; within the meaning of Canadian and United States securities laws, including the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that are predictive in nature, depend upon or refer
to future events or conditions, including, but not limited to, statements that reflect management&#146;s expectations regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities,
priorities, targets, goals, ongoing objectives, strategies and outlook of our company or Brookfield, as well as the outlook for North American and international economies for the current fiscal year and subsequent periods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The words &#147;expects,&#148; &#147;likely,&#148; &#147;anticipates,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;estimates,&#148;
&#147;seeks,&#148; &#147;intends,&#148; &#147;targets,&#148; &#147;projects,&#148; &#147;forecasts&#148; or negative versions thereof and other similar expressions, or future or conditional verbs such as &#147;may,&#148; &#147;will,&#148;
&#147;should,&#148; &#147;would&#148; and &#147;could&#148;, which are predictions of or indicate future events, trends or prospects, and which do not relate to historical matters, identify forward-looking statements. Although our company and
Brookfield Corporation believes that the anticipated future results, performance or achievements expressed or implied by the forward-looking statements and information are based upon reasonable assumptions and expectations, the reader should not
place undue reliance on forward-looking statements and information. The forward-looking statements and information involve known and unknown risks, uncertainties and other factors, many of which are beyond our company&#146;s or Brookfield&#146;s
control, which may cause the actual results, performance or achievements of our company or Brookfield to differ materially from anticipated future results, performance or achievement expressed or implied by such forward-looking statements and
information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Factors that could cause actual results to differ materially from those contemplated or implied by forward-looking
statements include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the intended structural equivalence of our exchangeable shares with Brookfield Class&nbsp;A
Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our ability to identify opportunities for growth or our ability to complete transactions as
planned or realize the anticipated benefits of our acquisitions or other investments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our operating subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our company being a holding company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks associated with our company being a &#147;SEC foreign issuer&#148; under Canadian securities regulations
and a &#147;foreign private issuer&#148; under U.S. securities law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the possibility of our company becoming an investment company under U.S. securities laws;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks associated with the effectiveness of our company&#146;s internal controls; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to exchanges of our exchangeable shares, or upon a liquidation or redemption event, including any
effect thereof on the market price of our exchangeable shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the terms and ownership of our share capital and our agreements with Brookfield Corporation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the trading price of our exchangeable shares relative to Brookfield Class&nbsp;A Shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the liquidity and <FONT STYLE="white-space:nowrap">de-listing</FONT> of our exchangeable
shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the market price volatility of our exchangeable shares and Brookfield Class&nbsp;A Shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to additional issuances of exchangeable shares and/or Brookfield Class&nbsp;A Shares, or other
securities that have rights and privileges that are more favorable than the rights and privileges afforded to our shareholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our ability to pay distributions equal to the levels currently paid by Brookfield Corporation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to foreign currency exchanges; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to shareholder protections under Bermuda law, which differ from the protection offered to
shareholders under Canadian law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to failure to realize anticipated benefits of our acquisition of Argo Group (as defined herein);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to failure to complete the AEL Acquisition (as defined herein); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to failure to realize anticipated benefits of AEL Acquisition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our assumptions and estimates when assessing reinsurance and insurance risks;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our growth strategy, including realizing the anticipated financial benefits from reinsurance
transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks associated with raising additional capital to fund growth; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to general market conditions in the reinsurance industry (including negative publicity related
thereto) and concentration risks in our investment portfolio; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our investment strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to changes in interest rates and credit spreads; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the valuation of our securities and investments and the determination of the amount of
allowances and impairments taken on such investments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the illiquidity of our company&#146;s assets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks to relating to a rating downgrade or the absence of a rating of any of our operating subsidiaries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the conduct of our counterparties to our reinsurance or indemnification arrangements or to the
derivatives we use to hedge our business risks; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the competition and consolidation in the reinsurance and insurance industries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to use of technology and cybersecurity attacks, including the failure to protect the
confidentiality of information; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our current and future indebtedness; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to general economic, political and market conditions, including changes in government policy and
legislation; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our capital requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to loss resulting from fraud, bribery, corruption other illegal acts, inadequate or failed
internal processes or systems, or from external events; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to public health crises, illness, epidemics or pandemics; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to becoming involved in disputes and possible litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to the highly regulated nature of our business and any future regulatory changes thereto;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to applicable capital ratios/calculations of our insurance subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to potential government intervention in the insurance industry and instability in the marketplace
for insurance products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to economic substance legislation enacted in Bermuda and the Cayman Islands;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to individuals who are members of BAM Re Partners Trust and also executives of Brookfield;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our dependence on Brookfield, and departure of some or all of Brookfield&#146;s professionals;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our inability to terminate certain agreements entered into with Brookfield;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to leveraging Brookfield&#146;s investment management and asset allocation capabilities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our organizational, ownership and operational management structure and investment management
relationship with Brookfield; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to terms of arrangements with Brookfield; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks associated with our failure to obtain or maintain licenses and/or other regulatory approvals as required
for the operations of our insurance subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to obtaining required work permits for employees in Bermuda and the Cayman Islands;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to senior executives of Brookfield Corporation exercising influence over our company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to our organizational, ownership and operational management structure potentially creating
conflicts of interest; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to Bermuda, Canadian and United States taxation laws; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risk and factors detailed in this prospectus under the heading &#147;Risk Factors&#148; as well as under
the heading &#147;Risk Factors&#148; in Brookfield Reinsurance&#146;s Annual Report and under the heading &#147;Business Environment and Risks&#148; in Brookfield Corporation&#146;s Annual Report and the other information incorporated by reference
in this prospectus, as updated by our subsequent filings with securities regulatory authorities in Canada and the United States, which are incorporated herein by reference, and those described in the applicable prospectus supplement.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We caution that the foregoing list of important factors that may affect future results is not exhaustive. The
forward-looking statements represent our views as of the date of this prospectus and the documents incorporated by reference herein and should not be relied upon as representing our views as of any date subsequent to such dates. While we anticipate
that subsequent events and developments may cause our views to change, we disclaim any obligation to update the forward-looking statements, other than as required by applicable law. For further information on these known and unknown risks, please
see &#147;Risk Factors&#148; in this prospectus and under the heading &#147;Risk Factors&#148; in Brookfield Reinsurance&#146;s Annual Report and under the heading &#147;Business Environment and Risks&#148; in Brookfield Corporation&#146;s Annual
Report and the other information incorporated by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reference in this prospectus, as updated by our subsequent filings with the SEC, which are incorporated herein by reference, and those described in the applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The risk factors included in this prospectus and in the documents incorporated by reference could cause our actual results and our plans and
strategies to vary from our <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements and information. In light of these risks, uncertainties and assumptions, the events described by our
<FONT STYLE="white-space:nowrap">forward-looking</FONT> statements and information might not occur. We qualify any and all of our <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements and information by these risk factors. Please keep
this cautionary note in mind as you read this prospectus and the documents incorporated by reference in this prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_3">
</A>WHERE YOU CAN FIND MORE INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our company and Brookfield Corporation are subject to the information and periodic reporting
requirements of the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), applicable to &#147;foreign private issuers&#148; (as such term is defined in Rule 405 under the Securities Act), and our company and Brookfield
Corporation will fulfill their obligations with respect to those requirements by filing or furnishing reports with the SEC. In addition, our company and Brookfield Corporation are required to file documents filed with the SEC with the securities
regulatory authority in each of the provinces and territories of Canada. The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding our company, Brookfield Corporation and other issuers
that file electronically with the SEC. The address of the SEC internet site is www.sec.gov. You are invited to read and copy any reports, statements or other information, other than confidential filings, that our company and Brookfield Corporation
file with the Canadian securities regulatory authorities. These filings are electronically available from SEDAR+ at www.sedarplus.com, the Canadian equivalent of the SEC&#146;s electronic document gathering and retrieval system. This information is
also available on at https://bnre.brookfield.com and https://bn.brookfield.com. The information on our company&#146;s and Brookfield Corporation&#146;s websites is not incorporated by reference into the Registration Statement and should not be
considered a part of the Registration Statement or this prospectus, and the references to our company&#146;s and Brookfield Corporation&#146;s websites in the Registration Statement and this prospectus are inactive textual references only. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our company and Brookfield Corporation are foreign private issuers, and therefore are exempt from the rules under the Exchange Act related to
the furnishing and content of proxy statements, and our company&#146;s and Brookfield Corporation&#146;s officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in
Section&nbsp;16 of the Exchange Act relating to their purchases and sales of our company&#146;s and Brookfield Corporation&#146;s securities. In addition, neither our company nor Brookfield Corporation is required under the Exchange Act to file
annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, our company and Brookfield Corporation intend to file with
the SEC, as soon as practicable, and in any event within four months after the end of each fiscal year, annual reports on Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT STYLE="white-space:nowrap">40-F,</FONT> as applicable,
containing financial statements audited by an independent registered public accounting firm. Our company and Brookfield Corporation also intend to furnish quarterly reports on Form <FONT STYLE="white-space:nowrap">6-K</FONT> containing unaudited
interim financial information for each of the first three quarters of each fiscal year. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_4"></A>DOCUMENTS
INCORPORATED BY REFERENCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following documents, filed with, or furnished to, the SEC are specifically incorporated by reference
in, and form an integral part of, this prospectus: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Reinsurance&#146;s Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1837429/000183742923000008/bamr-20221231.htm">Form
 <FONT STYLE="white-space:nowrap">20-F</FONT></A> for the year ended December&nbsp;31, 2022, filed with the SEC on March 31, 2023 (&#147;<B>Brookfield Reinsurance&#146;s Annual Report</B>&#148;), but excluding the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">vi </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
disclosure in the following sections of Brookfield Reinsurance&#146;s Annual Report that have been updated by Brookfield Reinsurance&#146;s U.S. GAAP Financial Statements and MD&amp;A (as defined
herein): </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Item 5. &#147;Operating and Financial Review and Prospects&#148; starting on page 92 of Brookfield
Reinsurance&#146;s Annual Report; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Item 18. &#147;Financial Statements&#148; at page 216 of Brookfield Reinsurance&#146;s Annual Report; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pages <FONT STYLE="white-space:nowrap">F-1</FONT> to <FONT STYLE="white-space:nowrap">F-92</FONT> of Brookfield
Reinsurance&#146;s Annual Report, containing the audited consolidated financial statements for Brookfield Reinsurance as of December&nbsp;31, 2022 and 2021 and for each of the three years in the period ended December&nbsp;31, 2022, together with the
accompanying notes, and the schedule of the condensed financial statements of Brookfield Reinsurance and the reports of the independent registered public accounting firm thereon </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(collectively, the &#147;<B><FONT STYLE="white-space:nowrap">20-F</FONT> Excluded Sections</B>&#148;); </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Reinsurance&#146;s recast audited combined consolidated financial statements as of December&nbsp;31,
2022 and 2021 and for each of the three years in the period ended December&nbsp;31, 2022, together with the accompanying notes, and the schedule of the condensed financial statements of Brookfield Reinsurance and the reports of the independent
registered public accounting firm thereon and management&#146;s discussion and analysis thereon, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1837429/000183742923000015/usgaap-20221231.htm">Exhibit 99.1
</A> to Brookfield Reinsurance&#146;s Form <FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on June&nbsp;28, 2023 (&#147;<B>Brookfield Reinsurance</B><B>&#146;</B><B>s U.S. GAAP Financial Statements and MD&amp;A</B>&#148;);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Reinsurance&#146;s unaudited condensed consolidated financial statements as at June&nbsp;30, 2023
and December&nbsp;31, 2022 and for the three and six months ended June&nbsp;30, 2023 and 2022 and management&#146;s discussion and analysis of Brookfield Reinsurance&#146;s financial condition and results of operations for the three and six months
ended June&nbsp;30, 2023 and 2022, in each case filed as <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1837429/000183742923000017/bamr-20230630_d2.htm">Exhibit&nbsp;99.1</A> to Brookfield Reinsurance&#146;s
Form <FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on August&nbsp;14, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Reinsurance&#146;s unaudited condensed consolidated financial statements as at September&nbsp;30,
2023 and December&nbsp;31, 2022 and for the three and nine months ended September&nbsp;30, 2023 and 2022 and management&#146;s discussion and analysis of Brookfield Reinsurance&#146;s financial condition and results of operations for the three and
nine months ended September&nbsp;30, 2023 and 2022, in each case filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000183742923000021/bnre-09302023x6kexhibit991.htm">Exhibit 99.1</A> to Brookfield Reinsurance&#146;s Form <FONT
STYLE="white-space:nowrap">6-K</FONT> with the SEC on November&nbsp;13, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Reinsurance&#146;s management information circular dated July&nbsp;
21, 2023, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523195311/d507647dex992.htm">Exhibit 99.2</A> to Brookfield Reinsurance&#146;s Form <FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on July&nbsp;27, 2023
(the &#147;<B>Brookfield Reinsurance Meeting Circular</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Reinsurance&#146;s management information circular dated September&nbsp;
30, 2022, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312522258916/d381365dex992.htm">Exhibit&nbsp;99.2</A> to Brookfield Reinsurance&#146;s Form <FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on October&nbsp;6,
2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Corporation&#146;s Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1001085/000100108523000007/bam-20221231.htm">Form
 <FONT STYLE="white-space:nowrap">40-F</FONT></A> for the year ended December&nbsp;31, 2022 (&#147;<B>Brookfield Corporation</B><B>&#146;</B><B>s Annual Report</B>&#148;), filed with the SEC on March&nbsp;24, 2023, which includes Brookfield
Corporation&#146;s (i)&nbsp;audited comparative consolidated financial statements and the notes thereto as of and for each of the two years in the period ended December&nbsp;31, 2022 and 2021, together with the reports of the independent registered
public accounting firm thereon, (ii)&nbsp;management&#146;s discussion and analysis of Brookfield Corporation&#146;s financial position as of December&nbsp;31, 2022 and 2021 and results of operations for each of the years ended December&nbsp;31,
2022 and 2021 and (iii)&nbsp;annual information form for the fiscal year ended December&nbsp;31, 2022 dated March&nbsp;24, 2023 (&#147;<B>Brookfield Corporation</B><B>&#146;</B><B>s AIF</B>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Corporation&#146;s unaudited condensed consolidated financial statements as at June&nbsp;30, 2023
and December&nbsp;31, 2022 and for the three and six months ended June&nbsp;30, 2023 and 2022 and management&#146;s discussion and analysis of Brookfield Corporation&#146;s financial condition and results of operations for the three and six months
ended June&nbsp;30, 2023 and 2022, in each case filed as <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1001085/000100108523000018/bn-20230630.htm">Exhibit&nbsp;99.1</A> to Brookfield Corporation&#146;s Form <FONT
STYLE="white-space:nowrap">6-K</FONT> with the SEC on August&nbsp;14, 2023; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">vii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Corporation&#146;s unaudited condensed consolidated financial statements as at September&nbsp;30,
2023 and December&nbsp;31, 2022 and for the three and nine months ended September&nbsp;30, 2023 and 2022 and management&#146;s discussion and analysis of Brookfield Corporation&#146;s financial condition and results of operations for the three and
nine months ended September&nbsp;30, 2023 and 2022, in each case filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1001085/000100108523000023/a2023-q3interimreportxbn.htm">Exhibit 99.1</A> to Brookfield Corporation&#146;s Form <FONT
STYLE="white-space:nowrap">6-K</FONT> with the SEC on November&nbsp;14, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Corporation&#146;s management information circular dated April&nbsp;
28, 2023, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1001085/000119312523139571/d497994dex992.htm">Exhibit 99.2</A> to Brookfield Corporation&#146;s Form <FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on May 9, 2023;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brookfield Corporation&#146;s management information circular dated September&nbsp;30, 2022 (the
&#147;<B>Brookfield Corporation Meeting Circular</B>&#148;), filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312522258916/d381365dex992.htm">Exhibit 99.2</A> to Brookfield Corporation&#146;s Form
<FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on October&nbsp;6, 2022, but excluding the disclosure in the following sections or subsections of the Brookfield Corporation Meeting Circular: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Information Concerning the Manager Post-Arrangement&#148; starting on page 59 of the Brookfield
Corporation Meeting Circular; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Other Matters to be Acted Upon&#148; starting on page 66 of the Brookfield Corporation Meeting Circular;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Certain Canadian Federal Income Tax Considerations&#148; starting on page 72 of the Brookfield
Corporation Meeting Circular; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Certain United States Federal Income Tax Considerations&#148; starting on page 80 of the Brookfield
Corporation Meeting Circular; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Legal Matters&#148; at page 92 of the Brookfield Corporation Meeting Circular; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Consents&#148; at page 93 of the Brookfield Corporation Meeting Circular; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Appendix E &#150; Information Concerning the Manager Post-Arrangement&#148;; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Appendix F &#150; Consolidated Financial Statements of Brookfield Asset Management Ltd.&#148;;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Appendix G &#150; Combined Consolidated <FONT STYLE="white-space:nowrap">Carve-Out</FONT> Financial
Statements of Brookfield Asset Management ULC&#148;; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Appendix H &#150; Unaudited Condensed Combined <FONT STYLE="white-space:nowrap">Carve-Out</FONT>
Financial Statements of Brookfield Asset Management ULC&#148; </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(collectively, the &#147;<B>Brookfield Corporation Meeting
Circular</B> <B>Excluded Sections</B>&#148;); </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the following acquisition-related documents filed with the SEC on August&nbsp;18, 2023: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the unaudited consolidated financial statements of American National Group, Inc. (&#147;<B>American
National</B>&#148;) as of March&nbsp;31, 2022 and December&nbsp;31, 2021, and for the three months ended March&nbsp;
31, 2022 and 2021, together with the notes and schedules thereto, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523215429/d522682dex992.htm">Exhibit 99.2</A> to Brookfield Reinsurance&#146;s Form <FONT
STYLE="white-space:nowrap">6-K</FONT> with the SEC on August&nbsp;18, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the audited consolidated financial statements of American National as of December&nbsp;31, 2021 and
December&nbsp;31, 2020, and for each of the two years in the period ended December&nbsp;
31, 2021, together with the notes and schedules thereto, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523215429/d522682dex991.htm">Exhibit 99.1</A> to Brookfield Reinsurance&#146;s Form
<FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on August&nbsp;18, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the unaudited consolidated financial statements of Argo Group International Holdings, Ltd. (&#147;<B>Argo
Group</B>&#148;) as of June&nbsp;30, 2023 and December&nbsp;31, 2022, and for the six months ended June&nbsp;
30, 2023 and 2022, together with the notes and schedules thereto, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523215429/d522682dex994.htm">Exhibit 99.4</A> to Brookfield Reinsurance&#146;s Form <FONT
STYLE="white-space:nowrap">6-K</FONT> with the SEC on August&nbsp;18, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the audited consolidated financial statements of Argo Group as of December&nbsp;31, 2022 and December&nbsp;31,
2021, and for each of the years in the three-year period ended December&nbsp;31, 2022, together with the notes and schedules thereto, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523215429/d522682dex993.htm">Exhibit
99.3</A> to Brookfield Reinsurance&#146;s Form <FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on August&nbsp;18, 2023; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">viii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the unaudited consolidated financial statements of American Equity Investment Life Holding Company
(&#147;<B>AEL</B>&#148;) and subsidiaries as of June&nbsp;30, 2023 and December&nbsp;31, 2022, and for the six months ended June&nbsp;
30, 2023 and 2022, together with the notes and schedules thereto, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523215429/d522682dex996.htm">Exhibit 99.6</A> to Brookfield Reinsurance&#146;s Form <FONT
STYLE="white-space:nowrap">6-K</FONT> with the SEC on August&nbsp;18, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the audited consolidated financial statements of AEL and subsidiaries as of December&nbsp;31, 2022 and
December&nbsp;31, 2021, and for each of the years in the three-year period ended December&nbsp;
31, 2022, together with the notes and schedules thereto, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523215429/d522682dex995.htm">Exhibit&nbsp;99.5</A> to Brookfield Reinsurance&#146;s Form
<FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on August&nbsp;18, 2023; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the combined statements of revenues and certain operating expenses of certain office and <FONT
STYLE="white-space:nowrap">mixed-use</FONT> real estate (the &#147;<B>Acquired RE Portfolio</B>&#148;) for the six months ended June&nbsp;30, 2023 (unaudited) and for the year ended December&nbsp;31, 2022, together with the report of the independent
auditor thereon, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523215429/d522682dex997.htm">Exhibit 99.7</A> to Brookfield Reinsurance&#146;s Form <FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on
August&nbsp;18, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the unaudited consolidated financial statements of Argo Group as of September&nbsp;30, 2023 and
December&nbsp;31, 2022, and for the nine months ended September&nbsp;
30, 2023 and 2022, together with the notes and schedules thereto, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312524008711/d703716dex992.htm">Exhibit&nbsp;99.2</A> to Brookfield Reinsurance&#146;s Form <FONT
STYLE="white-space:nowrap">6-K</FONT> with the SEC on January 16, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the unaudited consolidated financial statements of AEL and subsidiaries as of September&nbsp;30, 2023 and
December&nbsp;31, 2022, and for the nine months ended September&nbsp;
30, 2023 and 2022, together with the notes and schedules thereto, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312524008711/d703716dex993.htm">Exhibit&nbsp;99.3</A> to Brookfield Reinsurance&#146;s Form <FONT
STYLE="white-space:nowrap">6-K</FONT> with the SEC on January 16, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the unaudited condensed combined <I>pro forma</I> financial statements of Brookfield Reinsurance as at
June&nbsp;30, 2023, and for the six months ended June&nbsp;30, 2023 and the year ended December&nbsp;31, 2022, to give effect to the acquisition of American National, the Argo Acquisition (as defined herein), the AEL Acquisition (as defined herein)
and the acquisition of the Acquired RE Portfolio, filed as <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312524008711/d703716dex991.htm">Exhibit&nbsp;99.1</A> to Brookfield Reinsurance&#146;s Form
<FONT STYLE="white-space:nowrap">6-K</FONT> with the SEC on January 16, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the description of the class A exchangeable shares as set forth in Brookfield Reinsurance&#146;s registration
statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312521191781/d159986d8a12b.htm"><FONT STYLE="white-space:nowrap">Form&nbsp;8-A</FONT></A>, filed with the SEC on June&nbsp;16, 2021, pursuant to Section&nbsp;12(b) of the
Exchange Act, including any subsequent amendments or reports filed for the purpose of updating such description; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the description of the class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares as set forth in
Brookfield Reinsurance&#146;s registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1837429/000119312523276717/d600399d8a12b.htm"><FONT STYLE="white-space:nowrap">Form&nbsp;8-A</FONT></A>, filed with the SEC on November&nbsp;14,
2023, pursuant to Section&nbsp;12(b) of the Exchange Act, including any subsequent amendments or reports filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">20-F</FONT> Excluded Sections have not been incorporated by reference into, and do not form a part of
this prospectus since such sections have been updated by Brookfield Reinsurance&#146;s U.S. GAAP Financial Statements and MD&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Brookfield Corporation Meeting Circular Excluded Sections have not been incorporated by reference in, and do not form a part of this prospectus because they were prepared in respect of a specific transaction contemplated in the Brookfield
Corporation Meeting Circular, unrelated to the distribution of securities under this prospectus, and that transaction has been completed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All annual reports filed by our company and Brookfield Corporation with the SEC on Form <FONT STYLE="white-space:nowrap">20-F</FONT> or <FONT
STYLE="white-space:nowrap">Form&nbsp;40-F,</FONT> as applicable, and any Form <FONT STYLE="white-space:nowrap">6-K</FONT> filed or furnished with the SEC by our company and Brookfield Corporation that is identified in such form as being incorporated
by reference into the registration statement of which this prospectus forms a part, in each case, subsequent to the date of this prospectus and prior to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ix </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
termination of this offering, are incorporated by reference into this prospectus as of the date of the filing of such documents. Our company and Brookfield Corporation shall undertake to provide
without charge to each person to whom a copy of this prospectus has been delivered, upon the written or oral request of any such person to our company or Brookfield Corporation, a copy of any or all of the documents referred to above that have been
or may be incorporated into this prospectus by reference, excluding exhibits to such documents, unless such exhibits are specifically incorporated by reference into such documents. Requests for such copies should be directed to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Brookfield Reinsurance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Ideation
House, 1st Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 Pitts Bay Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Pembroke HM08 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Bermuda </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Telephone: (416) <FONT STYLE="white-space:nowrap">956-5141</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Brookfield Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 Bay
Street, Suite&nbsp;100 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toronto, Ontario M5J&nbsp;2T3 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Telephone: (416) <FONT STYLE="white-space:nowrap">359-8647</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Any statement contained in this prospectus, any prospectus supplement, any &#147;free writing prospectus&#148; or in a document
incorporated or deemed to be incorporated by reference in this prospectus, any prospectus supplement or any &#147;free writing prospectus&#148; shall be deemed to be modified or superseded, for the purposes of this prospectus, any prospectus
supplement or any &#147;free writing prospectus&#148;, as the case may be, to the extent that a statement contained in this prospectus, any prospectus supplement, any &#147;free writing prospectus&#148; or in any other subsequently filed or
furnished document which also is or is deemed to be incorporated by reference in this prospectus, any prospectus supplement or any &#147;free writing prospectus&#148;, as the case may be, modifies or supersedes that statement. The modifying or
superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of a modifying or superseding statement shall not be
deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that is required to be stated or that is
necessary to make a statement not misleading in light of the circumstances in which it was made. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus, any
prospectus supplement or any &#147;free writing prospectus&#148;, as the case may be. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">x </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_5"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information contained elsewhere in this prospectus or incorporated by reference in this prospectus. This
summary does not contain all of the information you should consider before investing in the exchangeable shares or the Brookfield Class&nbsp;A Shares. Before making an investment decision, you should read this entire prospectus carefully, especially
the section entitled &#147;Risk Factors,&#148; the financial statements and related notes thereto, the documents incorporated by reference in this prospectus and the other documents to which this prospectus refers. Some of the statements in this
prospectus constitute forward-looking statements that involve risks and uncertainties. See &#147;Cautionary Note Regarding Forward-Looking Statements&#148; for more information. See also the section entitled &#147;Where You Can Find More
Information.&#148; </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brookfield Reinsurance Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Brookfield Reinsurance was incorporated on December&nbsp;10, 2020 under the Companies Act 1981 of Bermuda, as amended (the &#147;<B>Bermuda
Act</B>&#148;), as an exempted company limited by shares. Our company operates a leading capital solutions business providing insurance and reinsurance services to individuals and institutions. Through our operating subsidiaries, we offer a broad
range of insurance products and services, including life insurance and annuities, personal and commercial property and casualty insurance. In doing so, we seek to match our liabilities with a portfolio of high-quality investments in order to
generate attractive, risk-adjusted returns within our business. We leverage our relationship with Brookfield in order to opportunistically source new business and deploy our capital in assets that are tailored to our investment needs. Our
relationship with Brookfield provides us with access to a diverse mix of leading alternative investment strategies that we believe are well-suited for this purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our class A exchangeable shares are listed on the NYSE and the TSX under the symbol &#147;BNRE&#148;. Our
<FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares are listed on the NYSE and the TSX under the symbol &#147;BNRE.A&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Brookfield Reinsurance&#146;s head and registered office as well as their principal executive offices are located at Ideation House, 1st
Floor, 94 Pitts Bay Road, Pembroke HM08 Bermuda, and its telephone number is <FONT STYLE="white-space:nowrap">+1&nbsp;(441)&nbsp;405-7811.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further information with respect to Brookfield Reinsurance is set forth in Brookfield Reinsurance&#146;s Annual Report, which is incorporated
by reference in this document. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brookfield Corporation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Brookfield Corporation is focused on compounding capital over the long term to earn attractive total returns for its shareholders. Today,
Brookfield Corporation&#146;s capital is deployed across three businesses &#150; Asset Management, Insurance Solutions and its Operating Businesses, generating substantial and growing free cashflows, all of which is underpinned by a conservatively
capitalized balance sheet. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Brookfield Class&nbsp;A Shares are listed on the NYSE and the TSX under the symbol &#147;BN&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Brookfield Corporation&#146;s principal executive offices are located at 181 Bay Street, Suite 100, Toronto, Ontario M5J 2T3, and its
telephone number is (416) <FONT STYLE="white-space:nowrap">359-8647.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Distribution Policy and Distribution History </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The declaration and payment of dividends on the Brookfield Class&nbsp;A Shares and class B limited voting shares (the &#147;<B>Brookfield
Class</B><B></B><B>&nbsp;B Shares</B>&#148;) of Brookfield Corporation are at the discretion of the board of </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directors of Brookfield Corporation. Dividends on the Brookfield Class&nbsp;A Shares and Brookfield Class&nbsp;B Shares are paid quarterly, at the end of March, June, September and December of
each year. The board of directors of Brookfield Corporation supports a stable and consistent dividend policy and will consider increasing dividends from time to time at a rate based on a portion of the growth rate in cash flow from operations per
share. Special dividends may also be declared from time to time to implement corporate strategic initiatives. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Acquisition of Argo Group International Holdings, Ltd. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;8, 2023, our company announced a definitive merger agreement to acquire Argo Group International Holdings, Ltd. in an <FONT
STYLE="white-space:nowrap">all-cash</FONT> transaction for approximately $1.1&nbsp;billion (the &#147;<B>Argo Acquisition</B>&#148;). As part of the definitive merger agreement, each issued and outstanding Argo Group common share was converted into
the right to receive $30.00 in cash at closing of the merger, funded by existing cash on hand and liquidity available to Brookfield Reinsurance. The merger closed on November&nbsp;16, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Argo Group is a U.S. focused underwriter of specialty insurance products in the property and casualty market. Argo Group offers a full line of
products and services designed to meet the unique coverage and claims-handling needs of businesses. Argo Group and its insurance subsidiaries are rated <FONT STYLE="white-space:nowrap">&#145;A-&#146;</FONT> by Standard and Poor&#146;s. Argo
Group&#146;s insurance subsidiaries are rated <FONT STYLE="white-space:nowrap">&#145;A-&#146;</FONT> by A.M. Best. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Acquisition of American Equity
Investment Life Holding Company </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;4, 2023, our company entered into a definitive Agreement and Plan of Merger (the
&#147;<B>AEL Merger Agreement</B>&#148;) with Arches Merger Sub, Inc., an Iowa corporation and a wholly owned subsidiary of Brookfield Reinsurance (&#147;<B>Merger Sub</B>&#148;), American Equity Investment Life Holding Company, an Iowa corporation,
and solely for the purposes set forth in the AEL Merger Agreement, Brookfield Asset Management Ltd. (&#147;<B>BAM</B>&#148;), whereby our company will acquire the outstanding common equity of AEL that it does not already own for aggregate
consideration of $55.00 per AEL share in a transaction that values AEL at approximately $4.3&nbsp;billion (the &#147;<B>AEL Acquisition</B>&#148;). AEL shareholders will receive a combination of $38.85 in cash consideration and a number of class A
limited voting shares of BAM (&#147;<B>BAM Shares</B>&#148;) having a value equal to $16.15 (based on the undisturbed <FONT STYLE="white-space:nowrap">90-day</FONT> volume-weighted average share price of the BAM Shares as of June&nbsp;23, 2023),
subject to adjustment in certain circumstances as described in the AEL Merger Agreement (the &#147;<B>BAM Stock Consideration</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to facilitate Brookfield Reinsurance&#146;s obligations to fund the BAM Stock Consideration, Brookfield Reinsurance intends to
acquire from Brookfield Corporation the BAM Shares required to satisfy the BAM Stock Consideration. Subject to this occurring, BAM&#146;s public float will increase by approximately 10%, and Brookfield Corporation&#146;s interest in Brookfield Asset
Management ULC will decrease from 75% to approximately 73%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the AEL Acquisition, Brookfield Reinsurance is expected to
issue class C shares of Brookfield Reinsurance to Brookfield Corporation in exchange for the BAM Shares and cash consideration that will be used by our company to fund the AEL Acquisition. As of the date of this document, the number of class C
shares to be issued to Brookfield Corporation has not been determined; however, we expect to issue up to 90,000,000 class C shares to Brookfield Corporation. No exchangeable shares of our company will be issued in connection with the AEL
Acquisition. See the unaudited condensed combined <I>pro forma</I> financial statements of Brookfield Reinsurance as at June&nbsp;30, 2023, and for the six months ended June&nbsp;30, 2023 and the year ended December&nbsp;31, 2022, filed as Exhibit
99.1 to Brookfield Reinsurance&#146;s Form 6-K filed with the SEC on January&nbsp;16, 2024, for further information on the <I>pro forma</I> impact of the AEL Acquisition and the other transactions described therein. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">AEL is an industry leader in the development and sale of fixed index and fixed rate annuity
products. The company was founded in 1995 and is headquartered in West Des Moines, Iowa with additional offices in Charlotte, NC, New York, NY and Miami, FL. AEL is licensed to sell insurance products in all 50 states and the District of Columbia,
writing over $4&nbsp;billion of annuity products annually. AEL&#146;s products are sold primarily through independent insurance agents, as well as banks and broker-dealers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The AEL Acquisition is expected to close in the first half of 2024, subject to closing conditions customary for a transaction of this type,
including receipt of insurance regulatory approvals in relevant jurisdictions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exchange Offer </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;14, 2023, our company announced the results of its previously announced offer (the &#147;<B>Offer</B>&#148;) through which
holders of Brookfield Class&nbsp;A Shares were given the opportunity to voluntarily exchange their Brookfield Class&nbsp;A Shares for newly-issued class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis. The Offer closed on November&nbsp;16, 2023. Under the Offer, our company took up 32,934,574 Brookfield Class&nbsp;A Shares and issued 32,934,574 <FONT
STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares in exchange. Immediately following the completion of the Offer, there were 10,450,952 class A exchangeable shares and 32,934,574 class <FONT STYLE="white-space:nowrap">A-1</FONT>
exchangeable shares issued and outstanding. The Brookfield Class&nbsp;A Shares tendered in the Offer were retained by Brookfield Reinsurance for investment purposes. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in the exchangeable shares and the Brookfield Class&nbsp;A Sharee is subject to certain risks. Before making an investment
decision, you should carefully consider the risks described in this prospectus and under the heading &#147;Risk Factors&#148; in Brookfield Reinsurance&#146;s Annual Report and under the heading &#147;Business Environment and Risks&#148; in
Brookfield Corporation&#146;s Annual Report and the other information incorporated by reference in this prospectus, as updated by our subsequent filings with the SEC pursuant to Sections 13(a), 14 or 15(d) of the Exchange Act, which are incorporated
herein by reference, and those described in the applicable prospectus supplement. The risks and uncertainties described therein and herein are not the only risks and uncertainties we face. Additional risks and uncertainties not presently known by
Brookfield Reinsurance or Brookfield Corporation, or that Brookfield Reinsurance or Brookfield Corporation currently believe are not material, may also materially and adversely impact the business, operations, financial condition, financial
performance, cash flows, reputation or prospects of Brookfield Reinsurance or Brookfield Corporation. For more information see &#147;Documents Incorporated by Reference.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to the <FONT STYLE="white-space:nowrap">Class&nbsp;A-1</FONT> Exchangeable Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>As a result of certain regulatory limitations in our <FONT STYLE="white-space:nowrap">bye-laws,</FONT> certain holders of
<FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares may be unable to convert their <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares into class&nbsp;A exchangeable shares. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">bye-laws</FONT> provide that no holder of our <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT>
exchangeable shares will be permitted to convert its <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares into our class&nbsp;A exchangeable shares unless the requesting holder has provided satisfactory evidence to us (in our
reasonable determination) that either (i)&nbsp;it and its affiliates will not, after giving effect to the conversion, directly or indirectly, beneficially own, control or hold with the power to vote more than 9.9% of our class&nbsp;A exchangeable
shares or (ii)&nbsp;it and its affiliates have received all required regulatory approvals and consents or, if applicable, exemptions or waivers, to beneficially own, control or hold with the power to vote more than 9.9% of our class&nbsp;A
exchangeable shares (the &#147;<B>Regulatory Condition</B>&#148;). Investing in our <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares are subject to this risk and other risks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the Regulatory Condition in our <FONT STYLE="white-space:nowrap">bye-laws,</FONT> investors may be limited in their ability to convert
their class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares into class A exchangeable shares, which could in effect limit such investors in their ability to vote on matters requiring approval of shareholders of Brookfield
Reinsurance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares generally have no voting rights. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise required by Bermuda law and other than in the limited circumstances described in our
<FONT STYLE="white-space:nowrap">bye-laws,</FONT> holders of <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares generally will have no voting rights. Our class&nbsp;A exchangeable shares and class B shares are the only
classes that carry full voting rights. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Holders of <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares are unable to convert
their <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares into class&nbsp;A exchangeable shares during certain periods. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">bye-laws</FONT> prohibit holders of <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable
shares from converting their <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares into class&nbsp;A exchangeable shares during (i)&nbsp;the calendar month in which quarterly distributions are paid to holders of exchangeable
shareholders or (ii)&nbsp;during the period commencing 10 business days prior to a record date for any special dividend or stock distribution and up to and including on the payment date for such dividend (the &#147;<B>Blackout Period</B>&#148;). Any
notice given to the transfer agent to exercise the right of conversion on the <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares purported to be delivered to our company during a Blackout Period will be deemed to have been
received on the business day immediately following the date on which a Blackout Period expires. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to the AEL Acquisition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Failure to complete the AEL Acquisition could negatively impact the future business and financial results of our company. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The closing of the AEL Acquisition is subject to satisfaction or waiver of a number of customary closing conditions, including receipt of<B>
</B>insurance regulatory approvals in relevant jurisdictions. Although we expect that the AEL Acquisition will close in the first half of 2024, there is no guarantee that the AEL Acquisition will close on such timeline, or at all. If the AEL
Acquisition is not completed, the ongoing businesses of our company may be adversely affected and our company will be subject to several risks, including (i)&nbsp;having to pay certain costs relating to the AEL Acquisition, such as legal,
accounting, financial advisor, filing, printing and mailing fees; and (ii)&nbsp;the focus of management teams on the AEL Acquisition instead of on pursuing other opportunities that could be beneficial; in each case, without realizing any of the
benefits of having the AEL Acquisition completed. In addition, if the AEL Acquisition is not completed, our company may experience negative reactions from the financial markets and from regulators, rating agencies, prospective customers and
counterparties and other insurance industry participants. If the AEL Acquisition is not completed, these risks may still materialize and may adversely affect the business, financial results and stock prices of our company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Following the AEL Acquisition, we may not realize the anticipated benefits of the AEL Acquisition. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we are successful in closing the AEL Acquisition, we may fail to realize some or all of the anticipated benefits of the AEL
Acquisition, including as a result of potential unknown liabilities and expenses within the business that were not identified by us during due diligence, or because of changes in our business or the business or industry of AEL between the time we
entered into the AEL Merger Agreement and closing of the AEL Acquisition. Furthermore, following the AEL Acquisition, the size and complexity of our business will increase significantly, and we may be exposed to additional risk factors that we are
not exposed to through our existing business, including risks relating to AEL&#146;s business. Our future success depends, in part, upon our ability to manage our expanded business, and mitigate such risk factors, which may pose substantial
challenges for management, including challenges related to the management and monitoring of new operations and associated increased costs and complexity. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless stated otherwise in the applicable prospectus supplement accompanying this prospectus, we expect to use the net proceeds of the sale of
exchangeable shares for general corporate purposes. We will not receive any proceeds from any sales of exchangeable shares offered by a selling securityholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The actual application of proceeds from the sale of any particular offering of exchangeable shares covered by this prospectus will be
described in the applicable prospectus supplement relating to the offering. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_8"></A>DESCRIPTION OF OUR EXCHANGEABLE
SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following description of class A exchangeable shares and class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable
shares sets forth certain general terms and provisions of the class A exchangeable shares and class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares, as applicable. This description is in all respects subject to and qualified in its
entirety by applicable law and the provisions of our company&#146;s <FONT STYLE="white-space:nowrap">bye-laws.</FONT> Through the rights and governance structures described in this prospectus and in the documents incorporated by reference, each
exchangeable share is intended to provide its holder with an economic return that is equivalent to that of a Brookfield Class&nbsp;A Share. Consequently, we expect that the market price of our class A exchangeable shares, and our class <FONT
STYLE="white-space:nowrap">A-1</FONT> exchangeable shares should be impacted by the market price of the Brookfield Class&nbsp;A Shares and the business performance of Brookfield Corporation. Except for the voting rights and the conversion rights
described below, the rights, privileges, restrictions and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions attached to the class A exchangeable shares as a class and the class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares as a class are identical in all respects.
<B>Certain material U.S. and Canadian federal income tax considerations relating to such exchangeable shares will be described in a prospectus supplement.</B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights of Class&nbsp;A Exchangeable Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of class A exchangeable shares will be entitled to receive notice of, and to attend and vote at, all meetings of our shareholders,
other than meetings at which only holders of a specified class or series of shares are entitled to vote or as otherwise required by law. Except as set out below under &#147;&#151; Election of Directors&#148;, each holder of class A exchangeable
shares will be entitled to cast one vote for each class&nbsp;A exchangeable share held at the record date for determination of shareholders entitled to vote on any matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise expressly provided in our <FONT STYLE="white-space:nowrap">bye-laws</FONT> or as required by law, all matters to be
approved by shareholders must be approved by: (i)&nbsp;a majority or, where a higher threshold is specified under applicable law, the higher percentage of the votes cast by holders of class A exchangeable shares who vote in respect of the
resolution, and (ii)&nbsp;a majority or, where a higher threshold is specified under applicable law, the higher percentage of the votes cast by the holder of our class B shares who vote in respect of the resolution. As a result, all matters that
require shareholder approval must be approved by the holder of the class B shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Election of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the election of directors, holders of class A exchangeable shares will be entitled to elect <FONT STYLE="white-space:nowrap">one-half</FONT>
of the board. Our <FONT STYLE="white-space:nowrap">bye-laws</FONT> provide that each holder of a class A exchangeable share has the right to cast a number of votes equal to the number of votes attached to the class A exchangeable shares held by the
holder multiplied by the number of directors to be elected by the holder and all holders of class A exchangeable shares entitled to vote with such holder in the election of directors. A holder may cast all such votes in favor of one candidate or
distribute such votes among its candidates in any manner the holder sees fit. Where a holder has voted for more than one candidate without specifying the distribution of votes among such candidates, the holder shall be deemed to have divided the
holder&#146;s votes equally among the candidates for whom the holder voted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights of <FONT STYLE="white-space:nowrap">Class&nbsp;A-1</FONT>
Exchangeable Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise required by law, each holder of <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT>
exchangeable shares shall be entitled to notice of, and to attend, any meetings of shareholders of our company (except meetings at which only holders of another specified class or series of shares are entitled to vote), but shall not be entitled to
vote at any such meeting. The <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares are <FONT STYLE="white-space:nowrap">non-voting</FONT> to address certain insurance regulatory restrictions on ownership, but are otherwise
intended to be economically equivalent in all respects to our class&nbsp;A exchangeable shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conversion Right of Holders of <FONT
STYLE="white-space:nowrap">Class&nbsp;A-1</FONT> Exchangeable Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable law and the Regulatory Condition, a holder
of <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares will be entitled, from time to time, to convert their <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares into class&nbsp;A exchangeable shares on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis (the &#147;<B>Conversion Right</B>&#148;). No holder will be permitted to convert its <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT>
exchangeable shares, and our company will not authorize or effect any conversions of <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares, unless the requesting holder has provided satisfactory evidence to our company that it
meets the Regulatory Condition as determined by our company acting reasonably. See &#147;Risk Factors &#151; Risks Relating to the <FONT STYLE="white-space:nowrap">Class&nbsp;A-1</FONT> Exchangeable Shares &#151; As a result of certain regulatory
limitations in our <FONT STYLE="white-space:nowrap">bye-laws,</FONT> certain holders of class A 1 exchangeable shares may be unable to convert their class A 1 exchangeable shares into class A exchangeable shares&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Conversion Right will be exercisable in accordance with the share conditions, which are attached to the
<FONT STYLE="white-space:nowrap">bye-laws.</FONT> The right of conversion may be exercised, provided the Regulatory Condition is satisfied, by notice in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
writing given to the transfer agent (a &#147;<B>Conversion Notice</B>&#148;), which notice shall specify the number of <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares
that the <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shareholder desires to have converted. No Conversion Notice will be accepted during the Blackout Period. See &#147;Risk Factors &#151; Risks Relating to the <FONT
STYLE="white-space:nowrap">Class&nbsp;A-1</FONT> Exchangeable Shares &#151; Holders of <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares are unable to convert their <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT>
exchangeable shares into class&nbsp;A exchangeable shares during certain periods&#148;. If a holder of class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares holds such class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable
shares through a broker, such holder may contact its broker to request an exchange on such holder&#146;s behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A converting holder will
have no further right, with respect to any <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares so converted, to receive any distributions on such shares with a record date on or after the Conversion Notice Date, without regard
to the time of day on the Conversion Notice Date at which the exchange is completed. For greater certainty, a converting holder will, despite a notice of conversion being delivered, be entitled to receive any distributions on class&nbsp;A
exchangeable shares and <FONT STYLE="white-space:nowrap">class&nbsp;A-1</FONT> exchangeable shares that have a record date prior to the Conversion Notice Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of
exchangeable shares will be entitled to receive distributions as and when declared by our board subject to receipt of sufficient shareholder approval (where applicable) and the prior rights of the holders of all classes and series of the
Class&nbsp;A Senior Preferred Shares and Class&nbsp;B Senior Preferred Shares and any other shares ranking senior to the class A exchangeable shares or class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares with respect to priority in
payment of distributions. It is expected that each exchangeable share will receive distributions at the same time and in the same amount as the cash dividends paid on each Brookfield Class&nbsp;A Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the prior rights of holders of all classes and series of Senior Preferred Shares at the time outstanding having prior rights as to
distributions, and in preference to the Junior Preferred Shares and class C shares of our company, each exchangeable share will entitle its holder to cumulative distributions per share in an amount equal to (i)&nbsp;the amount of any cash dividend
made on a Brookfield Class&nbsp;A Share multiplied by (ii)&nbsp;the exchange factor (which initially shall be one, subject to adjustment in the event of certain dilutive or other capital events by our company or Brookfield Corporation) determined in
accordance with our <FONT STYLE="white-space:nowrap">bye-laws</FONT> and in effect on the payment date of such distribution, which we refer to as the exchangeable distribution. See Item 10.B &#147;Memorandum and
<FONT STYLE="white-space:nowrap">Bye-Laws</FONT> &#151; Exchange by Holder &#151; Adjustments to Reflect Certain Capital Events&#148; in Brookfield Reinsurance&#146;s Annual Report which is incorporated by reference into this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the full amount of an exchangeable distribution is not paid concurrently with a dividend on the Brookfield Class&nbsp;A Shares, then the
unpaid amount of such exchangeable distribution shall accrue and accumulate (without interest), whether or not our company has earnings, whether or not there are funds legally available for the payment thereof and whether or not such exchangeable
distribution has been earned, made or authorized. Any exchangeable distribution payment made shall first be credited against the earliest accumulated but unpaid exchangeable distribution due which remains payable, which we refer to as unpaid
distributions. All exchangeable distributions shall be paid prior and in preference to any dividends or distributions on the class&nbsp;C shares. The holders of class A exchangeable shares and class <FONT STYLE="white-space:nowrap">A-1</FONT>
exchangeable shares shall not be entitled to any distributions from our company other than the exchangeable distributions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
exchangeable shares may be consolidated or split in the event of, and equally with, a share consolidation or stock split of the Brookfield Class&nbsp;A Shares. As an alternative, stock dividends may be paid in lieu of stock splits concurrently with
a stock split of the Brookfield Class&nbsp;A Shares. In that case, the stock dividend on the exchangeable shares will be paid in additional exchangeable shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exchange by Holder </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time before
the 15th business day prior to the date of any redemption, holders of exchangeable shares shall have the right to exchange all or a portion of their exchangeable shares with Brookfield Corporation for one
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Brookfield Class&nbsp;A Share per exchangeable share held (subject to adjustment in the event of certain dilutive or other capital events by our company or Brookfield Corporation as described
below in &#147;&#151; Adjustments to Reflect Certain Capital Events&#148;) or its cash equivalent based on the NYSE closing price of one Brookfield Class&nbsp;A Share on the date that the request for exchange is received by our transfer agent (or if
not a trading day, the next trading day thereafter) plus all unpaid distributions, if any (the form of payment to be determined at the sole election of Brookfield Corporation), subject to certain limitations described below if Brookfield Corporation
is unable to maintain an effective registration statement. If you hold exchangeable shares through a broker, please contact your broker to request an exchange on your behalf. If you are a registered holder of exchangeable shares, please contact our
transfer agent and follow the process described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Amended and Restated Rights Agreement dated as of March&nbsp;21,
2023 between Brookfield Corporation, Brookfield Reinsurance and Wilmington Trust, National Association (the &#147;<B>Rights Agreement</B>&#148;) Brookfield Corporation has agreed it will satisfy, or cause to be satisfied, any request made pursuant
to our <FONT STYLE="white-space:nowrap">bye-laws</FONT> to exchange such exchangeable shares for Brookfield Class&nbsp;A Shares or its cash equivalent, plus unpaid distributions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligation to satisfy a request for exchange is the obligation of Brookfield Corporation, and our company has no obligation to deliver
Brookfield Class&nbsp;A Shares or cash, to deliver any unpaid distributions, or to cause Brookfield Corporation to do so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of
exchangeable shares who wishes to exchange one or more of his or her exchangeable shares with Brookfield Corporation for Brookfield Class&nbsp;A Shares or its cash equivalent is required to complete and deliver a notice of exchange in the form
available from our transfer agent. Upon receipt of a notice of exchange, Brookfield Corporation shall, subject to the remarketing mechanisms described below, within ten (10)&nbsp;business days after the date that the notice of exchange is received
by our transfer agent, or the specified exchange date, deliver to the tendering holder of exchangeable shares, in accordance with instructions set forth in the notice of exchange, one Brookfield Class&nbsp;A Share per exchangeable share held
(subject to adjustments in the event of certain capital events by our company or Brookfield Corporation as described below in &#147;&#151; Adjustments to Reflect Certain Capital Events&#148;) or its cash equivalent based on the NYSE closing price of
one Brookfield Class&nbsp;A Share on the date that the request for exchange is received by our transfer agent (or if not a trading day, the next trading day thereafter) plus all unpaid distributions, if any (the form of payment to be determined at
the sole election of Brookfield Corporation). Notwithstanding the foregoing, for so long as there is not an effective registration statement with respect to the delivery of Brookfield Class&nbsp;A Shares in connection with the exchange right,
Brookfield Corporation will not be able to effect exchanges for Brookfield Class&nbsp;A Shares and will not be required to effect exchanges for cash that would result in the payment of an amount in excess of $5,000,000 in the aggregate over any 30
consecutive calendar day period; provided that such limit will not apply for more than 90 consecutive calendar days during any 12&nbsp;calendar month period. Upon completion of the exchange of any exchangeable shares as described herein, the holder
of exchangeable shares who has exchanged their exchangeable shares will have no further right, with respect to any exchangeable shares so exchanged, to receive any distributions on the exchangeable shares on or after the date on which such
exchangeable shares are exchanged. For greater certainty, a tendering holder will, despite a notice of exchange being delivered, be entitled to receive any distributions on the exchangeable shares that have a record date or otherwise accrued prior
to the date on which such notice of exchange is received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the limitations on exchange as described above, in the event that a
tendering holder of exchangeable shares has not received the number of Brookfield Class&nbsp;A Shares or its cash equivalent (the form of payment to be determined by Brookfield Corporation in its sole discretion) in satisfaction of the tendered
exchangeable shares on or prior to the specified exchange date, then, pursuant to the Rights Agreement, the holder of the subject exchangeable shares, or the rights agent, on behalf of the holder of the subject exchangeable shares, will have the
right to institute and maintain any suit, action or proceeding against Brookfield Corporation to enforce the obligations of Brookfield Corporation to exchange our exchangeable shares for Brookfield Class&nbsp;A Shares (or their cash equivalent) plus
unpaid distributions. For a further description of the Rights Agreement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
see&nbsp;10.C &#147;Material Contracts &#151; Rights Agreement&#148; and Item 10.B &#147;Memorandum and <FONT STYLE="white-space:nowrap">Bye-Laws</FONT> &#151; Rights Agreement&#148; in
Brookfield Reinsurance&#146;s Annual Report which is incorporated by reference into this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Remarketing Mechanism</I>. In
accordance with our <FONT STYLE="white-space:nowrap">bye-laws,</FONT> Brookfield Corporation may engage an agent to remarket exchangeable shares tendered for exchange and deliver Brookfield Class&nbsp;A Shares under certain conditions, in which case
the tendering holder&#146;s exchangeable shares would be purchased (and remain in circulation in the hands of another holder) rather than being exchanged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>No Fractional Shares.</I> No fractional Brookfield Class&nbsp;A Shares will be issued or delivered upon exchange of exchangeable shares. In
lieu of any fractional Brookfield Class&nbsp;A Shares to which the tendering holder of exchangeable shares would otherwise be entitled at Brookfield Corporation&#146;s election, Brookfield Corporation will pay an amount in cash equal to the
Brookfield Class&nbsp;A Share value on the trading day immediately preceding the applicable specified exchange date multiplied by such fraction of a Brookfield Class&nbsp;A Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Adjustments to Reflect Certain Capital Events.</I> The exchange factor (which initially shall be one) is subject to adjustment in
accordance with our company&#146;s <FONT STYLE="white-space:nowrap">bye-laws</FONT> to reflect certain capital events, including (i)&nbsp;if Brookfield Corporation declares or pays a dividend to its shareholders consisting wholly or partly of
Brookfield Class&nbsp;A Shares or if or our company declares or pays a distribution to our shareholders consisting wholly or partly of exchangeable shares, in each case, without a corresponding dividend or distribution, as applicable, being paid by
the other entity; (ii)&nbsp;if Brookfield Corporation or our company splits, subdivides, reverse-splits or combines its outstanding Brookfield Class&nbsp;A Shares or exchangeable shares, as applicable, without a corresponding event occurring at the
other entity; (iii)&nbsp;if Brookfield Corporation or our company distributes any rights, options or warrants to all or substantially all holders of its Brookfield Class&nbsp;A Shares or exchangeable shares to convert into, exchange for or subscribe
for or to purchase or to otherwise acquire Brookfield Class&nbsp;A Shares or exchangeable shares (or other securities or rights convertible into, exchangeable for or exercisable for Brookfield Class&nbsp;A Shares or exchangeable shares), as
applicable, without a corresponding distribution of comparable rights, options or warrants by the other entity; (iv)&nbsp;if Brookfield Corporation effects a <FONT STYLE="white-space:nowrap">spin-off,</FONT> unless a corresponding event (or a
distribution/equivalent compensation) occurs at our company in respect of the exchangeable shares; (v)&nbsp;if Brookfield Corporation distributes to all or substantially all holders of Brookfield Class&nbsp;A Shares evidences of its indebtedness or
assets (including securities), or rights, options or warrants to convert into, exchange for or subscribe for or to purchase or to otherwise acquire such securities but excluding all distributions where a comparable distribution (or the cash
equivalent) is made by our company; or (vi)&nbsp;if Brookfield Corporation or one of its subsidiaries makes a payment in respect of a tender or exchange offer for the Brookfield Class&nbsp;A Shares (but excluding for all purposes any exchange or
tender offer to exchange Brookfield Class&nbsp;A Shares for exchangeable shares or any other security economically equivalent to Brookfield Class&nbsp;A Shares), to the extent that the cash and value of any other consideration included in the
payment per Brookfield Class&nbsp;A Share exceeds certain thresholds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Recirculation of Exchangeable Shares</I>. Brookfield Corporation
may, in certain circumstances as further described in our <FONT STYLE="white-space:nowrap">bye-laws,</FONT> transfer the exchangeable shares acquired by Brookfield Corporation upon an exchange (the &#147;<B>Recirculation Right</B>&#148;). The
Recirculation Right allows the exchangeable shares of our company that are acquired by Brookfield Corporation following exchange to remain in circulation under certain circumstances, thereby supporting our company&#146;s efforts to enhance liquidity
for our shareholders. The Recirculation Right may be exercised by Brookfield Corporation provided that prior notice of the transfer is given to our company confirming (i)&nbsp;the number of exchangeable shares to be transferred (the
&#147;<B>recirculated exchangeable shares</B>&#148;), (ii) the approval by the Brookfield Corporation board of directors of the issuance of the Brookfield Class&nbsp;A Shares issuable on exchange of the recirculated exchangeable shares
(&#147;<B>Additional Brookfield Class</B><B></B><B>&nbsp;A Shares</B>&#148;), (iii) if the exchangeable shares are then listed on any stock exchange, the approval of the stock exchange for the listing of the Additional Brookfield Class&nbsp;A Shares
and (iv)&nbsp;the satisfaction by Brookfield Corporation of the securities laws applicable to the transfer (provided that this shall not be interpreted as requiring our company to register such recirculated exchangeable share). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board will have the right, subject to the prior written consent of Brookfield Corporation, as the sole holder of the class C shares, and
upon sixty days&#146; prior written notice to holders of exchangeable shares, to redeem all of the then outstanding exchangeable shares at any time and for any reason, in its sole discretion and subject to applicable law, including without
limitation following the occurrence of any of the following redemption events: (i)&nbsp;the total number of class A exchangeable shares outstanding decreases by 50% or more over any <FONT STYLE="white-space:nowrap">six-month</FONT> period;
(ii)&nbsp;the daily market value of the class&nbsp;A exchangeable shares (based on the closing price on the NYSE on each trading day)&nbsp;(A) is less than $250&nbsp;million for more than six consecutive months or (B)&nbsp;decreases by 50% or more
from its high over any three-month period; (iii)&nbsp;a person acquires 90% of the Brookfield Class&nbsp;A Shares in a take-over bid (as defined by applicable securities law); (iv) shareholders of Brookfield Corporation approve an acquisition of
Brookfield Corporation by way of arrangement, amalgamation or similar transaction; (v)&nbsp;shareholders of Brookfield Corporation approve a restructuring or other reorganization of Brookfield Corporation or a liquidation, insolvency or <FONT
STYLE="white-space:nowrap">winding-up</FONT> of Brookfield Corporation is pending; (vi)&nbsp;there is a pending sale of all or substantially all of Brookfield Corporation&#146;s assets; (vii)&nbsp;there is a change of law (whether by legislative,
governmental or judicial action), administrative practice or interpretation, or a change in circumstances of our company and our shareholders, that may result in adverse tax consequences for our company or our shareholders; or (viii)&nbsp;our board,
in its sole discretion, concludes that the holders of exchangeable shares are adversely impacted by a fact, change or other circumstance relating to our company. For greater certainty, shareholders do not have the ability to vote on such redemption
and the board&#146;s decision to redeem all of the then outstanding exchangeable shares will be final. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any such redemption event,
the holders of exchangeable shares shall be entitled to receive pursuant to such redemption one Brookfield Class&nbsp;A Share per exchangeable share held (subject to adjustment in the event of certain capital events by our company or Brookfield
Corporation as described above in &#147;&#151; Exchange by Holder&nbsp;&#151; Adjustments to Reflect Certain Capital Events&#148;) or its cash equivalent based on the NYSE closing price of one Brookfield Class&nbsp;A Share on the trading day
immediately preceding the announcement of such redemption plus all unpaid distributions, if any (the form of payment to be determined at the election of our company). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, upon any redemption event, Brookfield Corporation may elect to acquire all of the outstanding exchangeable
shares in exchange for one Brookfield Class&nbsp;A Share per exchangeable share held (subject to adjustment in the event of certain capital events by our company or Brookfield Corporation as described above in &#147;&#151; Exchange by Holder &#151;
Adjustments to Reflect Certain Capital Events&#148;) or its cash equivalent based on the NYSE closing price of one Brookfield Class&nbsp;A Share on the trading day immediately preceding the announcement of such redemption plus all unpaid
distributions, if any (the form of payment to be determined at the election of Brookfield Corporation). Shareholders are not entitled to vote on Brookfield Corporation&#146;s exercise of the overriding call right described in the preceding
sentences. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Brookfield
Corporation, as the sole holder of our class C shares, will have the right, subject to applicable law, to require our company to commence a liquidation of our company following the occurrence of certain events. See Item 10.B &#147;Memorandum and <FONT
STYLE="white-space:nowrap">Bye-Laws</FONT> &#151; Class&nbsp;C Shares &#151; Liquidation&#148; in Brookfield Reinsurance&#146;s Annual Report which is incorporated by reference in this prospectus for more information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any liquidation, dissolution or winding up of our company or any other distribution of our assets among our shareholders for the purpose
of winding up our affairs, including whether substantially concurrent with the liquidation, dissolution or winding up of Brookfield Corporation or any other distribution of Brookfield Corporation&#146;s assets among its shareholders for the purpose
of winding up its affairs, and subject to the prior rights of holders of all classes and series of Senior Preferred Shares and any other class of shares of our company ranking in priority or ratably with the exchangeable shares and after the payment
in full of any unpaid </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
distributions, the holders of exchangeable shares shall be entitled to one Brookfield Class&nbsp;A Share per exchangeable share held (subject to adjustment in the event of certain capital events
by our company or Brookfield Corporation as described above in &#147;&#151; Exchange by Holder &#151; Adjustments to Reflect Certain Capital Events&#148;) or its cash equivalent based on the NYSE closing price of one Brookfield Class&nbsp;A Share on
the trading day immediately preceding announcement of such liquidation, dissolution or winding up (the form of payment to be determined at the election of our company). If, upon any such liquidation, dissolution or winding up, the assets of our
company are insufficient to make such payment in full, then the assets of our company will be distributed among the holders of exchangeable shares and class B shares ratably in proportion to the full amounts to which they would otherwise be
respectively entitled to receive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, upon any liquidation, dissolution or winding up of our company,
Brookfield Corporation may elect to acquire all but not less than all of the outstanding exchangeable shares for one Brookfield Class&nbsp;A Share per exchangeable share (subject to adjustment in the event of certain capital events by our company or
Brookfield Corporation as described above in &#147;&#151; Exchange by Holder &#151; Adjustments to Reflect Certain Capital Events&#148;) plus all unpaid distributions, if any. The acquisition by Brookfield Corporation of all the outstanding
exchangeable shares will occur on the day prior to the effective date of the liquidation, dissolution or winding up of our company. Shareholders are not entitled to vote on Brookfield Corporation&#146;s exercise of the overriding call right
described in the preceding sentences. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Book-Based System </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exchangeable shares may be represented in the form of one or more fully registered share certificates held by, or on behalf of, CDS or DTC,
as applicable, as custodian of such certificates for the participants of CDS or DTC, registered in the name of CDS or DTC or their respective nominee, and registration of ownership and transfers of the exchangeable shares may be effected through the
book-based system administered by CDS or DTC, as applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Treatment of Exchangeable Shares in Connection with a Takeover Bid, Issuer Bid or Tender
Offer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exchangeable shares are not Brookfield Class&nbsp;A Shares and will not be treated as Brookfield Class&nbsp;A Shares for
purposes of the application of applicable Canadian and U.S. rules relating to takeover bids, issuer bids and tender offers. Neither, Brookfield Class&nbsp;A Shares, the class A exchangeable shares or the class
<FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares are securities of the same class. As a result, holders of exchangeable shares will not be entitled to participate in an offer or bid made to acquire Brookfield Class&nbsp;A Shares,
unless such offer is extended to holders of class A exchangeable shares and holders of the class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares and holders of Brookfield Class&nbsp;A Shares will not be entitled to participate in an
offer or bid made to acquire class A exchangeable shares or class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares, unless such offer is extended to holders of Brookfield Class&nbsp;A Shares. In the event of a takeover bid for
Brookfield Class&nbsp;A Shares, a holder of exchangeable shares who would like to participate would be required to first tender his or her exchangeable shares for exchange, in order to receive a Brookfield Class&nbsp;A Share, or the cash equivalent,
at the election of Brookfield Corporation, pursuant to the exchange right. If an issuer tender offer or issuer bid is made for the Brookfield Class&nbsp;A Shares at a price in excess of the market price of the Brookfield Class&nbsp;A Shares and a
comparable offer is not made for the exchangeable shares, then the exchange factor for the exchangeable shares may be adjusted. See &#147;&#151; Exchange by Holder &#151; Adjustments to Reflect Certain Capital Events&#148; above for more information
on the circumstances in which adjustments may be made to the exchange factor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Choice of Forum for Bermuda Act and U.S. Securities Act Claims </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our <FONT STYLE="white-space:nowrap">bye-laws,</FONT> unless we consent in writing to the selection of an alternative forum (and
our company will always provide such consent with respect to the Superior Court of Justice of the Province of Ontario, Canada and appellate Courts thereof), the Supreme Court of Bermuda shall, to the fullest extent permitted by law, be the sole and
exclusive forum for any dispute that arises concerning the Bermuda Act or out </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of or in connection with our <FONT STYLE="white-space:nowrap">bye-laws,</FONT> including any question regarding the existence and scope of our <FONT STYLE="white-space:nowrap">bye-laws</FONT>
and/or whether there has been any breach of the Bermuda Act or our <FONT STYLE="white-space:nowrap">bye-laws</FONT> by an officer or director (i.e., the Bermuda Forum Provision.) The Bermuda Forum Provision will not apply to any causes of action
arising under the Securities Act or the Exchange Act. In addition, our <FONT STYLE="white-space:nowrap">bye-laws</FONT> further provide that unless we consent in writing to the selection of an alternative forum, the federal courts of the United
States shall be the sole and exclusive forum for resolving any complaint filed in the United States asserting a cause of action arising under the Securities Act (i.e., the U.S. Federal Forum Provision). Our
<FONT STYLE="white-space:nowrap">bye-laws</FONT> provide that any person or entity purchasing or otherwise acquiring any interest in our exchangeable shares is deemed to have notice of and consented to the Bermuda Forum Provision and the U.S.
Federal Forum Provision; provided, however, that shareholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder. The Bermuda Forum Provision and the U.S.
Federal Forum Provision in our <FONT STYLE="white-space:nowrap">bye-laws</FONT> may impose additional litigation costs on shareholders in pursuing any such claims. Additionally, the forum selection clauses in our
<FONT STYLE="white-space:nowrap">bye-laws</FONT> may limit our shareholders&#146; ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage the filing of
lawsuits against us and our directors, officers and employees, even though an action, if successful, might benefit our shareholders. See Item 3.D &#147;Risk Factors &#151; Risks Relating to the Exchangeable Shares &#151; Our <FONT
STYLE="white-space:nowrap">bye-laws</FONT> designate specific courts in Bermuda as the exclusive forum for certain litigation that may be initiated by our shareholders, which could limit our shareholders&#146; ability to obtain a desired judicial
forum for disputes with us.&#148; in Brookfield Reinsurance&#146;s Annual Report which incorporated by reference in this prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_9">
</A>DESCRIPTION OF BROOKFIELD CLASS A SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following description sets forth certain general terms and provisions of the
Brookfield Class&nbsp;A Shares. The particular terms and provisions of Brookfield Class&nbsp;A Shares offered by a prospectus supplement, and the extent to which the general terms and provisions described below may apply thereto, will be described
in such prospectus supplement. For a more detailed description of the Brookfield Class&nbsp;A Shares, please refer to the Brookfield AIF, as updated by Brookfield Corporation&#146;s subsequent filings with the SEC that are incorporated by reference
in this prospectus. Certain material U.S. and Canadian federal income tax considerations related to such Brookfield Class&nbsp;A Shares will be described in a prospectus supplement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Priority </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Brookfield Class&nbsp;A
Shares rank on parity with the Brookfield Class&nbsp;B Shares and rank after the Brookfield Class&nbsp;A Preference Shares, Brookfield Corporation&#146;s Class&nbsp;AA Preference Shares and any other senior-ranking shares outstanding from time to
time with respect to the payment of dividends (if, as and when declared by the board of directors of Brookfield Corporation) and return of capital on the liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of Brookfield
Corporation or any other distribution of the assets of Brookfield Corporation among its shareholders for the purpose of winding up its affairs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the prior rights of the holders of the Brookfield Corporation Class&nbsp;A Preference Shares, the Class&nbsp;AA Preference Shares
and any other senior-ranking shares outstanding from time to time, the Brookfield Class&nbsp;A Shares rank on parity with the Brookfield Class&nbsp;B Shares with respect to the payment of dividends (if, as and when declared by the board of directors
of Brookfield Corporation) and the return of capital on the liquidation, dissolution or winding up of Brookfield Corporation or any other distribution of the assets of Brookfield Corporation among its shareholders for the purpose of winding up its
affairs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as
set out below under &#147;&#151; Election of Directors&#148;, each holder of Brookfield Class&nbsp;A Shares and Brookfield Class&nbsp;B Shares is entitled to notice of, and to attend and vote at, all meetings of Brookfield Corporation&#146;s
shareholders, other than meetings at which holders of only a specified class or series may vote, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall be entitled to cast one vote per share. Subject to applicable law and in addition to any other required shareholder approvals, all matters to be approved by shareholders (other than the
election of directors), must be approved: by a majority or, in the case of matters that require approval by a special resolution of shareholders, at least
66&nbsp;<SUP STYLE="vertical-align:top">2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>%, of the votes cast by holders of Brookfield Class&nbsp;A Shares who vote in respect of the resolution or special resolution, as the case may be; and by
a majority or, in the case of matters that require approval by a special resolution of shareholders, at least 66&nbsp;<SUP STYLE="vertical-align:top">2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>%, of the votes cast by holders of
Brookfield Class&nbsp;B Shares who vote in respect of the resolution or special resolution, as the case may be. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Election of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the election of directors, holders of Brookfield Class&nbsp;A Shares, together, in certain circumstances, with the holders of certain series
of Brookfield Class&nbsp;A Preference Shares, are entitled to elect <FONT STYLE="white-space:nowrap">one-half</FONT> of the board of directors of Brookfield Corporation, provided that if the holders of Brookfield Class&nbsp;A Preference Shares,
Series 2 become entitled to elect two or three directors, as the case may be, the numbers of directors to be elected by holders of Brookfield Class&nbsp;A Shares, together, in certain circumstances, with the holders of certain series of Brookfield
Class&nbsp;A Preference Shares, shall be reduced by the number of directors to be elected by holders of Brookfield Class&nbsp;A Preference Shares, Series 2. Holders of Brookfield Class&nbsp;B Shares are entitled to elect the other <FONT
STYLE="white-space:nowrap">one-half</FONT> of the board of directors of Brookfield Corporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_10"></A>SELLING
SECURITYHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates in part to the offer and resale from time to time by selling securityholders to be named in a
prospectus supplement, or their permitted transferees, of up to 765,488 class A exchangeable shares and up to 243,104 class <FONT STYLE="white-space:nowrap">A-1</FONT> exchangeable shares. The selling securityholders previously acquired such
exchangeable shares in connection with the exchange from time to time of exchangeable shares for Brookfield Class&nbsp;A Shares in accordance with the exchange mechanism described under &#147;Description of Out Exchangeable Shares&#151;Exchange by
Holder.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling securityholders may from time to time offer and sell any or all of the exchangeable shares pursuant to this
prospectus and any accompanying prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot advise you as to whether any selling securityholder will in fact sell
any or all of the exchangeable shares it owns. As such, we are unable to declare the number of exchangeable shares that the selling securityholder will retain after any such sale. In addition, the selling securityholders may sell, transfer or
otherwise dispose of, at any time and from time to time, exchangeable shares in transactions exempt from the registration requirements of the Securities Act after the date of this prospectus. See &#147;Plan of Distribution.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_11"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Issues </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell the exchangeable
shares to or through underwriters or dealers and may also sell the exchangeable shares directly to purchasers or through agents. The distribution of the exchangeable shares may be effected from time to time in one or more transactions at a fixed
price or prices. If offered on a <FONT STYLE="white-space:nowrap">non-fixed</FONT> price basis, including sales of exchangeable shares in transactions that are deemed
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> offerings&#148; within the meaning of Rule 415(a)(4) of the Securities Act, the exchangeable shares may be offered at market prices prevailing at the
time of sale, at prices determined by reference to the prevailing price of a specified security in a specified market or at prices to be negotiated with purchasers, in which case the compensation payable to an underwriter, dealer or agent in
connection with any such sale will be increased or decreased by the amount, if any, by which the aggregate price paid for the exchangeable shares by the purchasers exceeds or is less than the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
gross proceeds paid by the underwriter, dealer or agent to our company and/or the selling securityholders. The price at which the exchangeable shares will be offered and sold may vary from
purchaser to purchaser and during the period of distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of the exchangeable shares, underwriters,
dealers or agents may receive compensation from our company, the selling securityholders or from other parties, including in the form of underwriters&#146;, dealers or agents&#146; fees, commissions or concessions. Underwriters, dealers and agents
that participate in the distribution of the exchangeable shares may be deemed to be underwriters and any such compensation received by them from our company and/or the selling securityholders and any profit on the resale of the exchangeable shares
by them may be deemed to be underwriting commissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each prospectus supplement relating to the offering of exchangeable shares will set
forth the terms of the offering of the exchangeable shares, including, to the extent applicable, the names of any underwriters or agents, the purchase price or prices of the offered exchangeable shares, the proceeds to us or any selling
securityholder, as the case may be, from the sale of the offered exchangeable shares, the underwriting discounts and commissions and any discounts, commissions and concessions allowed or reallowed or paid by any underwriter to other dealers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If so indicated in the applicable prospectus supplement, we may authorize dealers or other persons acting as our agents to solicit offers by
certain institutions to purchase the offered exchangeable shares directly from us pursuant to contracts providing for payment and delivery on a future date. These contracts will be subject only to the conditions set forth in the applicable
prospectus supplement which will also set forth the commission payable for solicitation of these contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under agreements which may be
entered into by our company, underwriters, dealers and agents who participate in the distribution of exchangeable shares may be entitled to indemnification by us against certain liabilities, including liabilities under U.S. and Canadian securities
legislation, or to contribution with respect to payments which those underwriters, dealers or agents may be required to make in respect thereof. Those underwriters, dealers and agents may be customers of, engage in transactions with, or perform
services for, us in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exchangeable shares to be offered pursuant to this prospectus will be a new
issue of exchangeable shares (other than a secondary offering as detailed below). Certain broker-dealers may make a market in the exchangeable shares but will not be obligated to do so and may discontinue any market making at any time without
notice. No assurance can be given that any broker-dealer will make a market in the exchangeable shares or as to the liquidity of the trading market for the exchangeable shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Secondary Offerings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus may
also, from time to time, relate to the offering by a selling securityholder of its exchangeable shares. A selling securityholder may sell all or a portion of the exchangeable shares beneficially owned by it and offered from time to time directly or
through one or more underwriters, broker-dealers or agents. If the exchangeable shares are sold through underwriters or broker-dealers, the selling securityholders will be responsible for underwriting discounts or commissions or agent&#146;s
commissions. The selling securityholders may sell its exchangeable shares in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale, or at negotiated prices.
These sales may be effected in transactions which may involve crosses or block transactions, as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on any national securities exchange or quotation service on which the exchangeable shares may be listed or quoted
at the time of sale; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions otherwise than on exchanges or systems or in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing of options, whether such options are listed on an options exchange or otherwise;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker-dealer will attempt to sell the exchangeable shares as agent but may position
and resell a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">short sales; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT>
offerings,&#148; within the meaning of Rule&nbsp;415(a)(4) of the Securities Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">broker-dealers may agree with the selling securityholders to sell a specified number of such exchangeable shares
at a stipulated price per exchangeable share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a selling securityholder effects such transactions by selling its exchangeable shares to or through underwriters, broker-dealers or agents,
such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the selling securityholders or commissions from purchasers of the exchangeable shares for whom they may act as agent or to
whom they may sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved). In connection with sales of its
exchangeable shares or otherwise, the selling securityholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the exchangeable shares in the course of hedging in positions they assume. A selling
securityholder may also sell its exchangeable shares short and deliver exchangeable shares covered by this prospectus to close out short positions and to return borrowed securities in connection with such short sales. A selling securityholder may
also loan or pledge the exchangeable shares to broker-dealers that in turn may sell such exchangeable shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A selling securityholder
may pledge or grant a security interest in some or all of the exchangeable shares owned by it and, if it defaults in the performance of its secured obligations, the pledgees or secured parties may offer and sell the exchangeable shares from time to
time pursuant to this prospectus or any prospectus supplement, amending, if necessary, the list of selling securityholders to include, pursuant to a prospectus supplement, the pledgee, transferee or other successors in interest as selling
securityholders under this prospectus. A selling securityholder may also transfer and donate the exchangeable shares in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling
beneficial owners for purposes of this prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_12"></A>SERVICE OF PROCESS AND ENFORCEABILITY OF CIVIL
LIABILITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our company is organized under the laws of Bermuda. A substantial portion of our company&#146;s assets are located
outside of Canada and the United States and certain of the directors of our company may be residents of jurisdictions outside of Canada and the United States. Our company has expressly submitted to the jurisdiction of the Ontario courts and has
appointed an attorney for service of process in Ontario and in the United States. However, it may be difficult for investors to effect service within Ontario or elsewhere in Canada or the United States upon those directors who are not residents of
Canada or the United States, as applicable. Investors are advised that it may also not be possible for investors to enforce judgments obtained in Canada or the United </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
States against any person or company that is incorporated, continued or otherwise organized under the laws of a foreign jurisdiction or resides outside of Canada or the United States, even if the
party has appointed an agent for directors of our company or our directors since a substantial portion of our assets and the assets of such persons may be located outside of Canada and the United States. We have been advised by counsel that there is
no treaty in force between Canada and Bermuda or the United States and Bermuda providing for the reciprocal recognition and enforcement of judgments in civil and commercial matters. As a result, whether a Canadian or U.S. judgment would be capable
of being the subject of enforcement proceedings in Bermuda against us or our directors depends on whether the Canadian or U.S. court that entered the judgment is recognized by a Bermuda court as having jurisdiction over our company or our directors,
as determined by reference to Bermuda conflict of law rules. The courts of Bermuda would issue a valid, final and conclusive judgment <I>in personam</I> in respect of a judgment obtained in a Canadian or U.S. court pursuant to which a sum of money
is payable (other than a sum of money payable in respect of multiple damages, taxes or other charges of a like nature or in respect of a fine or other penalty) as long as (i)&nbsp;the court had proper jurisdiction over the parties subject to the
judgment according to Bermuda&#146;s conflicts of law principles; (ii)&nbsp;the court did not contravene the rules of natural justice of Bermuda; (iii)&nbsp;the judgment was not obtained by fraud; (iv)&nbsp;the enforcement of the judgment would not
be contrary to the public policy of Bermuda; and (v)&nbsp;there is due compliance with the applicable common law rules in Bermuda governing the enforcement of a foreign judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to and irrespective of jurisdictional issues, Bermuda courts will not enforce a provision of Canadian or U.S. federal securities
laws that is either penal in nature or contrary to public policy. It is the advice of our counsel that an action brought pursuant to a public or penal law, the purpose of which is the enforcement of a sanction, power or right at the instance of the
state in its sovereign capacity, is unlikely to be enforced by a Bermuda court. Specified remedies available under the laws of Canadian or U.S. jurisdictions, including specified remedies under Canadian securities laws or U.S. federal securities
laws, would not likely be available under Bermuda law or enforceable in a Bermuda court, as they may be contrary to Bermuda public policy. Further, no claim may be brought in Bermuda against our company or our directors in the first instance for a
violation of Canadian securities laws or U.S. federal securities laws because these laws have no extraterritorial application under Bermuda law and do not have force of law in Bermuda. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Brookfield Corporation is organized under the laws of Ontario, Canada. A substantial portion of Brookfield Corporation&#146;s assets are
located outside of Canada and the United States and certain of Brookfield Corporation&#146;s directors and officers, as well as certain of the experts named in this prospectus, may be residents of jurisdictions outside of Canada and the United
States. It may be difficult for investors to effect service within Ontario or elsewhere in Canada or the United States upon those directors, officer and experts who are not residents of Canada or the United States, as applicable. Investors are
advised that it may also not be possible for investors to enforce judgments obtained in Canada or the United States against any person or company that is incorporated, continued or otherwise organized under the laws of a foreign jurisdiction or
resides outside of Canada or the United States, even if the party has appointed an agent for service of process. Furthermore, it may be difficult to realize upon or enforce in Canada or the United States any judgment of a court of Canada or the
United States against Brookfield Corporation, its directors and officers, or the experts named in this prospectus since a substantial portion of Brookfield Corporation&#146;s assets and the assets of such persons may be located outside of Canada and
the United States. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_13"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in a prospectus supplement relating to exchangeable shares, the validity of the exchangeable shares offered
pursuant to this prospectus and other matters of Bermuda law will be passed upon for our company by Appleby (Bermuda) Limited and the validity of the Brookfield Class&nbsp;A Shares offered by this prospectus will be passed upon by Torys LLP. As at
the date of this prospectus, the partners and associates of each of Torys LLP and Appleby (Bermuda) Limited beneficially own, directly and indirectly, less than 1.0% of the outstanding securities or other property of Brookfield Corporation or our
company, and their respective associates or its affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_14"></A>TRANSFER AGENT AND REGISTRAR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for the exchangeable shares and Brookfield Class&nbsp;A Shares is TSX Trust Company, at its principal office
in Toronto, Ontario, Canada. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_15"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of Brookfield Reinsurance as of December&nbsp;31, 2022 and 2021, and for each of the three years in the period ended
December&nbsp;31, 2022, incorporated by reference in this document by reference to Brookfield Reinsurance&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">6-K</FONT> filed with the SEC on June&nbsp;28, 2023, and the effectiveness of
Brookfield Reinsurance&#146;s internal control over financial reporting, have been audited by Deloitte LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in
reliance upon the reports of such firm given their authority as experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of
Brookfield Corporation as of December&nbsp;31, 2022 and 2021, and for each of the two years in the period ended December&nbsp;31, 2022, incorporated by reference in this document, and the effectiveness of Brookfield Corporation&#146;s internal
control over financial reporting, have been audited by Deloitte LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm
given their authority as experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deloitte LLP is independent with respect to Brookfield Corporation and
Brookfield Reinsurance within the meaning of the Securities Act and the applicable rules and regulations thereunder adopted by the SEC and the Public Company Accounting Oversight Board (United States) and within the meaning of the rules of
professional conduct of the Chartered Professional Accountants of Ontario. The offices of Deloitte LLP are located at 8 Adelaide Street West, Toronto, Ontario M5H 0A9. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of American National Group, Inc. as of December&nbsp;31, 2021 and 2020, and for each of the two years in
the period ended December&nbsp;31, 2021, incorporated by reference in this document, have been audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are
incorporated by reference in reliance upon the report of such firm given their authority as experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
consolidated balance sheet of Argo Group International Holdings, Ltd. and subsidiaries as of December&nbsp;31, 2022, the related consolidated statements of income (loss), comprehensive income (loss), shareholders&#146; equity, and cash flows for the
year ended December&nbsp;31, 2022, and the related notes and financial statement schedules II, III, V and VI, incorporated by reference in this document, have been audited by KPMG LLP, an independent registered public accounting firm, as stated in
their report. Such financial statements and financial statement schedules are incorporated by reference in reliance upon the report of such firm given their authority as experts in accounting and auditing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated balance sheet of Argo Group International Holdings, Ltd. and subsidiaries as of December&nbsp;31, 2021, the related
consolidated statements of income (loss), comprehensive income (loss), shareholders&#146; equity, and cash flows for each of the years in the <FONT STYLE="white-space:nowrap">two-year</FONT> period ended December&nbsp;31, 2021, and the related notes
and schedules, incorporated by reference in this document, have been audited by Ernst&nbsp;&amp; Young LLP, an independent registered public accounting firm, as stated in their report. Such financial statements and financial statement schedules are
incorporated by reference in reliance upon the report of such firm given their authority as experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
consolidated balance sheet of AEL and subsidiaries as of December&nbsp;31, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), changes in stockholders&#146; equity, and cash
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
flows for each of the years in the <FONT STYLE="white-space:nowrap">two-year</FONT> period ended December&nbsp;31, 2022, and the related notes and schedules, incorporated by reference in this
document, have been audited by Ernst&nbsp;&amp; Young LLP, an independent registered public accounting firm, as stated in their report. Such financial statements and financial statement schedules are incorporated by reference in reliance upon the
report of such firm given their authority as experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated statements of operations, comprehensive
income, changes in stockholders&#146; equity, and cash flows of AEL and subsidiaries for the year ended December&nbsp;31, 2020, and the related notes (and financial statement schedules II to IV), incorporated by reference in this document, have been
audited by KPMG LLP, an independent registered public accounting firm, as stated in their report. Such financial statements and financial statement schedules are incorporated by reference in reliance upon the report of such firm given their
authority as experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The combined statement of revenues and certain operating expenses of the Acquired RE
Portfolio for the year ended December&nbsp;31, 2022, incorporated by reference in this document, have been audited by Deloitte LLP, an independent auditor, as stated in their report. Such financial statements are incorporated by reference in
reliance upon the report of such firm given their authority as experts in accounting and auditing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723741_16"></A>EXPENSES
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following are the estimated expenses of the offering of the securities being registered under the registration statement of which
this prospectus forms a part, all of which will be paid by our company. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">227,275.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE and TSX listing fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Blue sky fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and engraving costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> **</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be provided by a prospectus supplement or as an exhibit to a Report on Form
<FONT STYLE="white-space:nowrap">6-K</FONT> that is incorporated by reference into this registration statement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g723741g13w60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723741g13w60.jpg
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M)6<.TT\9 ,<T8Y0(E(R"<D]<8 J%_=5N^'\1NH_]$\R?WV\$O^3O:?XYN/\
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M5&NU;*DHUF9$Y""8K=DM<Z348 JRHAV)B^G&2'>(>8LF7J8/N/C[87<*PO1
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M">@!)]0&=>$@=20!ZR<:_<BA%2%43.11,Y0,0Y# <ARCZ@8IBB)3%$/4! 1
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MQ'MIABE9ZPA9DK3CZ\QXNX]R8A6TI$R#=0S:7K=CC/,54A[) 2":T=,1JIU
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M-2[N\$2JBJ,LS,0 % !)). -!2[SO3LJ)N.X.[L%1%L3,S,Q 554,2S,2
M220 ,Z-(UUPOO-I-RWMK=FMG]ILR9/VV;ZOY>R15JM?,A2V1J%@1]4L<S]MK
M$4VKUA>S-4M-Y0F(V/=VZ;?,9*)1.W&J0(+PY)F7M2LNV=HW7?=NH;?M]:OM
MIW"M7DDAA6&:XLLZ1R,70+)'$59A$JE6(/B/AN58V-3K;IMNS7[MZ]9FW 4K
M$T<<LS315#'"TB*$<O')*& ,C$,@QX:94,T@9VU7-HWNW4Q>GAO8O+T7=\>I
M6:)MY(5GC/&-35"?@V\BUC'@RM2J,++"1NC*OBBU]M]E6%4#+(J&33$C1V[A
MO:-JL>ZJ5=XI_#:+F:>>0<CD%ARR2,O7E'7&1Y:7=[?MTW*#W/<L"6$.LG*(
M8(_?J&"GFCC5N@8],X/F-5O<7NJ?5O\ CKGO\T'%-!HN,*/L'$Q5)QO3ZS0J
MA$+89PG)'C*M3X5E7J_'*24ECYU*/SLHF.:-C/9!ZY?NC)"N[<KN%%%3C$W!
M_#]B::>6F[2SR232,+5I>:25B[MRK,%&68G  4=@ .FK^'B?>Z\44$5P+%#&
MD4:&M5;ECC4(B\S0ECA0!EB2<9))SHXW.V:\GO>35<]A6UOEH#,,OR_V>637
MFKK!69F-O\UA*/M+NQ0:T&5B6#>ISCQ9\Q&*(T38'["LR($23*534ZE<<3PT
MC&KUEWGW-X4GOU:%;9C"/S9+ H #S$D^9.F;:LSGAV2V)&2PVU"?Q8SR,LK5
M@Y="N.0\Q)'+CE\L8TO4/S-.8J<PF'>G;4!'\Q-@<HIE^PI+.4H?8 <.G]@-
MC_DC;OZI!_<TI?V9W?\ E3</ZY8__IH]#D#9?RKG'ER4>_9ER-=LJ7AWDG*D
M<ZM^0+++VVRN6$993-XYFXFIQV]D%FS%#\BT14<&(@ET33 I0 .$_P 8UJ]3
M?)H:L$5>$05V$4,:QH"T8+$*@ R3U)QU.FGPK8GL[/%+8FEGE,TZF29VD<A7
MPH+.2Q '09/35M^2\DT7#N/[AE/)MEC:=0*#7Y*T6VS2ZIDF$/"Q3<[EVZ5\
MLJBZZHE*"+1DT27?2#Q5!BP;.7CA!!0;@@FLS15X(VEFF=8XXU&69V. !Y#U
MDG  R20 3J^FFBKQ23S.L<42,\CMV55&2?63Y  $DX !) T AS$?$2;3;'VJ
MP4O52QS^L^!&KITPB)*M+)QF:;PR3.=)*<L5U:'5?TH'A"E=,Z[17D8XC"+'
M:2MCL1BD41<>R<$[?1C27<42_<(#,KY-6$]^1(CA9L=B\P8-C*QIYJO=^+KU
MR1XZ+O2J@E5*'ELRCMSO*.L>>X2(J5R0SOWT/M;;Q=+]*K3UZM]HNLXY.=1Q
M,VV?EK'*KJ*#W'.M(S#MX\5.<WRCF.L8QA]1$1X-(H885"0Q1Q(.RQ(L:CXE
M0 ?HT)R2R2L7ED>1SW:1V=C\;,23_/K)6&-F]B-=9IK8,%YMR?BB3:+D7*:C
MW2=@F+H2F XH2D0S>DB)EDJ(='$?+L7K!T3J1RV5((E'7M;?1O(4N5*]A2,?
MNL2,P]JN1SH1Y,K!AY$:S5KMNFP>K9G@8'/[E(R ^>&4'E8'S5@5/8@Z,]Y-
MW/\ )#9BYUK5;= \!$YDLBB,1BS,T4S9UZ R?.&+VMZ?<X1H5"&KM\EC@):Y
M(P2$=7+2\.G7TH:%GC19+*K>)^#10BDW#:^=ZJ>^L56)=ZZ><L3G+/"OPPY+
MQCWY9DYBC%X=XK:Y(E'<N5;#X6"R $29_*.5  J2M\!DPDA/($1^7G*IX7NC
MK2RKGY&$W-MV\$?40D\/E^PNOF)BE_Y  !^OY^'UP=^#>V?DV?MMG28XJZ;_
M +A\=?\ 34KG61O#G_%<P?\ [F9L_9-;.,'&_P"#MOY6I]ICUEX0].U?D[/V
M>33(_A&:<6A+>=-S\+1@.\VC4C2>3BF^2JLJM"Y@SDLS83R=&G@+VO:'CV-?
MI/(9U;8@3>S6JR2S61:UR0]I@(Z-&Q,W<C"L?A7@^.[#'N6ZJQ@DPU:H"4\9
M/*:9E(<1MWCC4J9!AV;D(5P+B/BIZLLFW[:RB9,K8M8#>$_G%"#E3(O:21@P
M0DHH\0%D#<R-L1GS+\\XL^5<UY6R+8'2YW*LO=+_ &FQO2J',)NB"LK*.O94
M4^O:@W:@BW;)%(BW222(0A6?!1I5D$=>I6A0 #EB@C0''KY5&3ZR<DG))).E
MY-;M6',D]F>9R<\TLKN?H+,<8\@, =AK<#4/FS;TZ8V6*DL;YPMMJI3-RB:4
MQ%E&9E[YC.:8$.4SA@2#F9!5S5U7)2E*:8I3^N38=B9#/U&Y3MU*S<^&]HW2
M-EGJ1Q2D'ELUT6&=&/9BR "0 _!E#KWZ ]18;?ONY[:ZM!9D>,$<U>9FE@8#
MRY&)Y"?QHBC] .;'36FN?,J+9TSKFG-SB%2K;C,66LC947KJ+XTFC K9"N,S
M;585*2.U9'D$HL\N9BF^.R:&=E0!P9JW%04B6E.O[DJ5:@?G%6M!7Y\<O/X,
M2Q\_+D\O-RYQDXSC)[ZKK4YLV;%DKR&Q/-.4!Y@AED:3E#8&>7FQG SC.!VT
M47X3/^%[<KZ-\3_>>W\+_P"Z/_!MK^7L_5Q:-^ _X1N/R-?]>36 O%5?$"PO
M]3JB?MKS_P ;GW//0UO\YR_9:>M3CGTM7_-T/VFWH9D!$! 0$0$! 0$!Z" A
MZ@("'J @/S#P>Z#-9C'8O8,W3KG;,@]   ZY/NP] #Y@#K.?,'Y@XU?<-+^)
MU?ZO%_<UL>Z[?\9L?TTG][7F;'E;*-Q9#&V[)-^M4<)RJ"PL=PL,XR%0ANXB
M@M9.1=("<AOE%.*?<4WJ @/'W'6K1'FBKP1M^-'%&A_G50=?#SS2#$DTL@[X
M>1V&?7AB1KO,+T*@Y%NS"O9*S=3L!U18R8R%[N57R3<&;5,RI4S)LH+&-/M\
MP\>E*;S2IO4XB.$A3>;*HF "F^;<T\$)>O4ENR#[V&*2O$3T[L]B6)0/+WO.
MWJ4Z^ZT44TH2:S'4C^%+)'-( /8D$<C$^P\J^MAIA%R4-$^7]KICR5ROJSF^
MI;992LT:W@+YG9@]B?>$"P<'2?#28:BM7KZ2Q3%OEV:$D_AK"LXM<TLV;+RT
MFYCV<2PCDOQ5N^\WIUK[C4EVZNC%X:;!N5R,CQ6E( L, 2H9 (TR0J@EB6QP
MUM>TTX6GHV8[\[@)+:!7* ]?"2($M75L!BKDR.0"S%0H6]S@0T4:5:\VCXEV
M[GUB,A_]6/QT+PWZ!VGYE#^KI&[]Z9W/YY/^N=:[ZKZO9>W(SE2M>\'PK28O
MUW<//93RKT8N @XF*9+R<Y9+)*^2Y&-@H6-;+NWBZ39V]<&*C'Q3&1EGK"/=
M;NX[A6VNI+=ML5ABQD*.9W9B%1(UR.9V8X ) '5F95!(U*-*QN-J*I64-+*3
MCF/*BJH+,[M@\J*H))P2>BJ&8A25EB/PFS K1D\SQN$\4?J)IC(US$>,T46C
M57H K)LKI<K"X6?I]1,5-9>@QI@  .9 1,*95W9^Z,W,13VQ0OP7LSDL?43%
M$@"_$)F^/1U7X#& ;6X'.!S)7@P ?/$LCG(]1,0^+6^'B#-EGVG/+EJ&O6.9
MU^RM.>316"6DL9P1";)B.F5EL?([\%FI$$C.9R/3K=+ER(MTD5(R[2AD0;'(
M@'%/P707<]\DN3HIBIAK97&5]TR2'P%P<]$;GE7)^^B7.>NK3BVZ=OVB.I"Q
M$EO%7F[-[GC0>,>GFXY(F&/O96Q@@:7K\.K2FT=GRF?#^ZWPV Z!G7=.@?C<
MS!E"O1=VCL;V60EV-'Q=6YYHE)5Z(D*_%/8T;+<G,0Y;O+0-G,]BX=ZZ" CX
M1%W#.9N64/$?&=Y[DU3:I_<U6N[1&>,*9;#H2KNLC*?#BY@1'X>&8#G+D,%5
MG[#PI36K%:W*+Q[$R+*L+LPB@1AS(K(I7GD*D&02952>0)E2S6*;)\A_EP9_
MQ]+U>OX'K&!KD:/<)U7)6&VBM6E:Y+>4;V-Y(5UHZ1J]NC@7\L)&,GHU9=TS
M\Y*.E(9\=&3;4E'B_?*4RR/<DN19'B06CXBNN<D!R#)&V/O61A@XRK+E3;W.
M%]GMPM&E5*LF#X<U<<C(WD60'DD&?OE<$D9"LIPP75;+Z_WO5;/>5=><EH()
M73%%ND*M*KM/,]WRR"().X6Q10K%37-#V>!=QEBAS.$TG!XN4:&<(HK"=,CN
MH78=QIU[L!/A68A(H/WRGJ'C;'3FC<,C8R.93@D==**Y4EHVIZDP E@D:-L=
MF ZJZYZ\KJ5=<X/*PR >FB&_"^[A36.]GKCIY/RRRM!V!KDQ;Z7%+KF,A$Y=
MQ[#J3#Q>.1.8$FP6G',;/ISBB?Y9ZXJ%62[1*V$0"?N@;8DU"+<T4":G(L4K
M =6K3MRCF/GX<Y3DSV$LGKT7<$[@T-V3;W8^%;1I(E/9;$*\Q('8>)"K\Q[D
MQQCRU>?XC3;V:UJT.<8ZI,JM$7S:*SGQ.F]9K&;R$?C=M%KS.4'C-4I@'I)Q
M@1%&>E HF".NSM5(Z2Z22A1'@C;%O[P)I5YH=OC]TD$95IRP2NI^)N:8>1,.
M#D$C1-QAN#4]K,,;<LMY_ R#@B$*6G(_*7EB/LE)SD#2Z/AWZ46CI>4?R =<
MF. :!G[=6@#EG+&5*_%W>$QI8I&884C&54GFJ4C6F,I Q#Z,/9;E(0[EO(V0
MEG.[BH1=ZG -8)*0AW<S)*+B3C*\UR:GM4WN:M7=H6GC53-8D0E7978-X<08
M$1^'AF YRY5@JL[8.%*8J0V]RB\>Q.JRK"Y98H(V&45D!4O(RD-(),JI(0)E
M2[63['<B+ENY]H,M5X7 =8P5;E(]=*KY(PRV5J4Q7)3RC T?/(!FY2JUK9%6
M[ ?QEABG*CIJ*R;*0BGQT9)M1T>+]]IS+(]R2Y&&'B06CXJ2+GJ Y'B1G!/*
MR,,'&591RFXN<+[/:B:-:J59,'DFK@HR-CH2@/)(,]U=3D9PRGWP76[0Z[WS
M4W8+*^NF2TT N.*+8\K<@[9E5+'S3$4D)*O6:+*N4K@(BU5Q_$V2)!R1-R$;
M*-0<I)+@HF5V[?>AW*E6O09\*Q&' )!9&R5DC;'3FCD#1MCIS*<=-*.]4EH6
MYZ<V/$@D*$CLPP&1USUY9$*NN>O*PSUT0%X83<*:QGM9:-1)V66/CW8NNS-B
MJD4NN86L3E_'D*O/>W,$U#>2T&S8^B[''S)D@(O*.Z]4$3&/[ B3@,X_VQ)]
MNCW-%'C472.1@.K5IW" 'U^'.R%<_>B20],G17P5N#07GV]V/A7$9XUZX6Q"
MI?(\ASPJX8]V*1#R&BG>=%\+?<_Z*"_>JN<+WA;\(-J^<CZM]''$?H/<?D!]
M8FE<W'0.DEHD2L\Y]SJOR?-:---8YEPTV/G87-A<HY$9@J@IA.KVC8++LO&Q
MM;7,4@GR7::]*,91E*H"9*FP$BTEF:AK'(1B\&"R<+#<>)K^Z;@@-!&J>YX3
M_P#+DCI5E9G _P!!&ZLK*>LK@J?>*P8P3B,T>'Z6W4F(N,MGQYAT-9'MV&54
M/^ND1@P8?O:,&!YR"HY*"$G.2:+9LD^EYF8?IH(((IN'\G*2<@X!-)))(@*N
MGKYZZ6*1-,A57#EPJ!2@=0X )R2J*22JHBY).%554=23T 4 >P #U:$ &9L
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MRQJWY+.H;]!.G"1"$2(1-,A4TTRE(FF0H$(0A  I"$*4 *4I2@!2E*  4
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M /Z"=.'4446Z*3=NDF@@@F1%%%$A4TD44B@1-)),@ 1--,A2D(0H 4I0 I0
M  ..922223DGJ2>Y/K.NA.W;7Z<34TO!\3A7XF&YF'O&.31(\MFO>*;!/F2
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MWK*$.]20<R<C(3UC79QAYT8F/17$>^R;[>\;E:.K"#'4A8C*H3EI),$CQ92
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MV$QEK)K;A1<'>'-?<)8G=E(9,'>-L546CNQ(<HD.4SJLP48N8%"B)5.Y01.
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M;Q!54(FXR2J !BPD5@X'_P"DJ-+_ ->J*?A?8[!+-12-CYP/+ !\4<;K$/\
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MM4I/&J6):TO*4\2%VC?D8@LO,I!P2!D9P<#6W8K5[<?A68(K$88.(YD61.8
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M3(4I0 !IF9V+NS,S$EF8EF8GJ22<DDGN2<G1"JJBA44*J@*JJ JJH&  !@
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M &23@#SUEEVG;)Y'FFH5)97.7DD@C=V. ,LQ4DG  ZGL->]PGJ9K'K<^GI/
M& \3X;D;2T9,+(]QQ1X"I.IQE&K+N(]K*+0S)H=Z@S7=.%FR2YCD2475.0 $
MYA'#;W*_>"+=N6;2QDF,3S/*$+ !BH<G!( !([XUEK4*5,NU2K7K%P YAB2,
..L%)(#%0,@$DC/;.O_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
